Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

C3_MELANOMA_SKIN_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C43 Hospital discharge: ICD-9 — 172 Hospital discharge: ICD-8 — 172 Cause of death: ICD-10 — C43 Cause of death: ICD-9 — 172 Cause of death: ICD-8 — 172 Cancer registry: Topography ICD-O-3 — C44 Cancer registry: Morphology ICD-O-3 — 8720\|8721\|8726\|8730\|8742\|8743\|8744\|8745 Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	5888
4. Check minimum number of events None	5888
5. Include endpoints None	5888
6. Filter based on genotype QC (FinnGen only)	5888

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_MELANOMA_SKIN_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C43
HD_ICD_9	172
HD_ICD_8	172
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C43
COD_ICD_9	172
COD_ICD_8	172
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C44
CANC_TOPO_EXCL
CANC_MORPH	8720\|8721\|8726\|8730\|8742\|8743\|8744\|8745
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant melanoma of skin, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Malignant melanoma of skin

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5888	2814	3074
Unadjusted period prevalence (%)	1.17	0.96	1.36
Median age at first event (years)	62.95	58.90	66.67

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4035: Matched controls
40350

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

34.8

323.0

720

250

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

323.0

320

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

13.4

323.0

651

569

C61

ICD-10 Finland

Malignant neoplasm of prostate

358.0

323.0

326

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

1945.8

323.0

341

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

+∞

323.0

349

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

323.0

445

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

11.5

323.0

683

700

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

+∞

323.0

310

PJA12

NOMESCO Finland

Sentinel node biopsy

4054.0

323.0

1614

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

323.0

939

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

323.0

307

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

140.3

323.0

393

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

323.0

334

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

323.0

322

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

+∞

323.0

396

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

323.0

622

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

32.8

323.0

836

319

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

323.0

993

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

323.0

527

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

39.6

323.0

1744

760

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

323.0

356

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

323.0

633

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

323.0

863

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

18.2

323.0

965

685

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

9.0

323.0

989

1404

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

636

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

16.3

323.0

843

643

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

3185.6

320.8

306

R23.8

ICD-10 Finland

Other and unspecified skin changes

5.2

319.0

1156

2873

H02AB02

ATC

dexamethasone; systemic

31.1

314.2

425

152

JN4BD

NOMESCO Finland

Extensive body CT

9.4

311.6

693

874

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

+∞

309.3

293

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

305.1

289

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

+∞

302.9

287

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

+∞

298.6

283

C43

ICD-10 Finland

Malignant melanoma of skin

1538.3

294.1

283

S77

ICPC

Malignant neoplasm of skin

291.0

268.3

271

WF049

NOMESCO Finland

Radiotherapy of metastasis

+∞

266.6

253

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

+∞

265.5

252

ZZR00

NOMESCO Finland

Flap of skin

46.6

257.8

318

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

188.1

254.5

264

180

Kela drug reimbursment

Interferon alfa

+∞

251.7

239

S18

ICPC

Laceration/cut

3.1

247.2

2222

11433

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

204.8

242.4

250

L57.0

ICD-10 Finland

Actinic keratosis

5.7

240.6

769

1596

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

+∞

237.8

226

115

Kela drug reimbursment

Breast cancer

+∞

204.9

195

C43.7

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of lower limb, including hip

+∞

199.6

190

A04AA02

ATC

granisetron; systemic, transdermal

171.5

187.4

196

WF002

NOMESCO Finland

Radical radiotherapy

126.6

179.9

193

JN4AD

NOMESCO Finland

Body CT examination

8.1

179.4

429

585

116

Kela drug reimbursment

Prostate cancer

+∞

178.4

170

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

172.1

164

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

18.5

171.5

271

156

S82

ICPC

Naevus/mole

4.0

170.6

792

2345

C43.73

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip nodular

+∞

170.0

162

SPAT1153

SPAT

Removal of sutures

2.7

168.7

1664

8391

ZZA00

NOMESCO Finland

Split skin graft

10.9

167.8

335

332

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

14.8

167.4

289

209

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

13.5

166.2

299

238

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

165.7

158

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

159.4

152

WF003

NOMESCO Finland

Adjuvant radiotherapy

280.0

158.7

161

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

331.8

157.0

158

8720/3-C44.3

ICD-O-3

Malignant melanoma, NOS, of skin of other and unspecified parts of face

+∞

153.1

146

C43.6

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of upper limb, including shoulder

1505.4

147.8

143

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1480.1

145.7

141

D22

ICD-10 Finland

Melanocytic naevi

7.5

145.4

365

531

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

1455.0

143.6

139

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

143.6

137

8743/3-C44.5

ICD-O-3

Low cumulative sun damage melanoma of skin of trunk

+∞

141.4

135

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

+∞

139.3

133

C43.63

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder nodular

+∞

139.3

133

WX408

NOMESCO Finland

General anesthesy, balanced

2.7

139.0

1230

5672

C43.30

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face without histology

+∞

135.1

129

L03AB05

ATC

interferon alfa-2b; parenteral

116.4

135.0

146

XX3DW

NOMESCO Finland

Time consuming IT work

5.8

134.9

413

783

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.6

133.9

1274

6101

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

1330.9

133.0

129

XQ846

NOMESCO Finland

Digital dermatoscopy and registration of nevi

277.8

132.0

134

TQW99

NOMESCO Finland

Other minor procedure on skin

6.6

131.3

359

588

Z51.5

ICD-10 Finland

Palliative care

9.1

131.2

288

337

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

79.8

129.2

146

A03FA01

ATC

metoclopramide; systemic, rectal

3.4

128.2

719

2432

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

1266.5

126.7

123

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

126.7

121

167

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

+∞

125.6

120

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

42.9

125.6

157

ZX090

NOMESCO Finland

Other technic of radiotherapy

419.9

123.4

123

D22.6

ICD-10 Finland

Melanocytic naevi of upper limb, including shoulder

17.9

119.2

190

111

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

113.0

108

JN4CD

NOMESCO Finland

Very extensive body CT

9.5

112.6

241

269

L01XE23

ATC

[U] dabrafenib; oral

+∞

112.0

107

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

10.3

109.0

222

226

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

1076.0

107.9

105

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

31.5

106.8

143

362

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

+∞

106.7

102

D03.5

ICD-10 Finland

Melanoma in situ of trunk

77.3

105.9

120

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

1054.9

105.8

103

C43.9

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of skin, unspecified

1044.4

104.7

102

C43.32

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face 'superficial spreading' type

+∞

101.4

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

+∞

101.4

C43.49

ICD-10 Finland

Malignant melanoma of the scalp and neck other or unspecified histology

+∞

99.3

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

93.3

98.5

109

8720/3-C44.4

ICD-O-3

Malignant melanoma, NOS, of skin of scalp and neck

+∞

96.2

1509

Kela drug reimbursment

Dabrafenib (adjuvant treatment)

+∞

95.1

3024

Kela drug reimbursment

Dabrafenib and trametinib (adjuvant treatment)

+∞

95.1

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

95.1

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

939.4

94.3

C43.71

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip originating in lentigo maligna

+∞

93.0

L82

ICD-10 Finland

Seborrhoeic keratosis

2.6

92.5

802

3532

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.5

92.0

859

3941

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

89.9

C43.90

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin without histology

876.7

88.0

L02AE02

ATC

leuprorelin; implant, parenteral

21.6

86.1

128

XQ845

NOMESCO Finland

Dermatoscopy

13.9

83.9

147

109

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

7.2

83.7

211

305

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

83.6

1859

12367

C43.61

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna

+∞

83.6

HAC20

NOMESCO Finland

Total mastectomy

129.9

83.3

WF004

NOMESCO Finland

Palliative radiotherapy

+∞

82.6

L01XE25

ATC

[U] trametinib; oral

+∞

82.6

C43.00

ICD-10 Finland

Malignant melanoma of the lip without histology

+∞

81.5

L01AX03

ATC

temozolomide; systemic

+∞

81.5

HAB40

NOMESCO Finland

Wedge excision of mammary gland

22.0

81.3

120

C43.40

ICD-10 Finland

Malignant melanoma of the scalp and neck without histology

+∞

80.5

L01BC06

ATC

capecitabine; oral

+∞

80.5

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

17.0

79.9

129

L02BG04

ATC

letrozole; oral

15.4

79.7

134

ZX070

NOMESCO Finland

Intensity modified radiotherapy

793.3

79.6

EP1AE

NOMESCO Finland

Neck ultrasound examination

4.5

79.6

301

710

C43.42

ICD-10 Finland

Malignant melanoma of the scalp and neck: 'superficial spreading' type

+∞

79.4

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

10.4

79.2

160

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

272.7

78.8

A04AA01

ATC

ondansetron; systemic, rectal

6.6

78.5

211

334

L02BA01

ATC

tamoxifen; oral

88.9

78.2

9734

FHL

Excision and local plastic or associated free skin grafting

18.5

77.9

122

HA1AA

NOMESCO Finland

X-ray mammography

6.1

77.1

221

381

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

8.4

76.6

174

214

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

163.1

76.3

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

163.1

76.3

WZC30

NOMESCO Finland

Teaching

2.9

75.6

512

1924

L03AA13

ATC

pegfilgrastim; parenteral

379.1

75.0

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

103.3

74.1

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

116.5

74.1

ZXC50

NOMESCO Finland

Cryotherapy

6.7

73.1

195

305

L02BB03

ATC

bicalutamide; oral

710.2

71.3

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

70.0

Y77

ICPC

Malignant neoplasm prostate

237.2

68.4

WX402

NOMESCO Finland

General anaesthesia

2.5

67.5

605

2667

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

122.1

67.0

JN6AD

NOMESCO Finland

CT of torso and neck

25.3

66.5

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

50.9

66.4

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

5.9

66.3

195

347

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

65.8

ZX080

NOMESCO Finland

Image guided radiotherapy

648.1

65.1

A04AA55

ATC

palonosetron, combinations; systemic

+∞

64.7

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

90.3

64.1

PJA10

NOMESCO Finland

Exploration of lymph nodes

23.2

62.9

C50.99

ICD-10 Finland

Breast, unspecified

617.1

61.9

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

61.6

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

28.8

60.2

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

209.7

60.2

XQ848

NOMESCO Finland

Dermatological photography

6.1

60.0

170

288

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

5.8

60.0

178

320

DAB10

NOMESCO Finland

Partial excision of auricle

596.5

59.9

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

596.5

59.9

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

59.5

C43.74

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip acral

+∞

58.5

QCE99

NOMESCO Finland

Other excision or repair of lesion of skin of upper limb

17.3

58.2

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

202.8

58.2

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

22.5

57.6

8743/3-C44.6

ICD-O-3

Low cumulative sun damage melanoma of skin of upper limb and shoulder

+∞

57.4

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

11.7

56.6

107

8743/3-C44.7

ICD-O-3

Low cumulative sun damage melanoma of skin of lower limb and hip

+∞

56.4

8720/3-C44.2

ICD-O-3

Malignant melanoma, NOS, of external ear

+∞

56.4

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

65.9

56.4

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

72.0

56.2

NK6AN

NOMESCO Finland

Total body bone isotope imaging

27.0

55.7

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

285.2

55.3

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

55.3

C43.33

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face nodular

+∞

55.3

C50

ICD-10 Finland

Malignant neoplasm of breast

189.1

54.1

AA1BD

NOMESCO Finland

Extensive CT of head and brain

5.8

53.7

158

281

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

274.5

53.3

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

53.2

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

53.2

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

8.5

53.2

119

143

D03.31

ICD-10 Finland

Melanoma in situ in another or unspecified part of the face

39.4

52.3

L01EC02

ATC

dabrafenib; oral

+∞

52.2

L03AA02

ATC

filgrastim; parenteral

49.1

52.1

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.8

51.7

364

1385

ZZA50

NOMESCO Finland

Full thickness skin graft

56.2

51.6

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

60.8

51.4

R4110

NOMESCO Finland

Physiotherapy

1.8

50.6

1024

6306

WX110

NOMESCO Finland

Local anesthesy

1.7

50.3

2459

19585

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.1

50.1

292

982

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

81.2

50.0

8742/3-C44.9

ICD-O-3

Lentigo maligna melanoma of skin, NOS

+∞

49.0

D03.7

ICD-10 Finland

Melanoma in situ of lower limb, including hip

79.7

49.0

D03.6

ICD-10 Finland

Melanoma in situ of upper limb, including shoulder

49.8

49.0

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

25.0

48.9

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

91.2

48.9

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

22.5

48.8

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

483.3

48.4

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.9

48.0

165

351

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

48.0

C43.20

ICD-10 Finland

Malignant melanoma of the outer ear and in the external ear canal without histology

+∞

46.9

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

46.9

B01AB05

ATC

enoxaparin; parenteral

1.8

46.9

1125

7287

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

45.9

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

45.9

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

161.8

45.9

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

44.9

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

44.9

L01EE01

ATC

trametinib; oral

+∞

44.9

C43.43

ICD-10 Finland

Malignant melanoma of the scalp and neck nodular

+∞

44.9

D22.3

ICD-10 Finland

Melanocytic naevi of other and unspecified parts of face

5.9

44.8

130

228

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

442.2

44.3

N02BE01

ATC

paracetamol; systemic, rectal

1.8

44.0

3319

29184

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

15.9

43.9

17281

ICD-8 Finland

Malignant melanoma of skin, Lower limb

+∞

43.8

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

43.8

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

43.8

N02AA05

ATC

oxycodone; systemic

2.2

43.7

502

2464

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

5.5

43.6

134

252

S26

ICPC

Fear of cancer of skin

9.9

43.5

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

7.4

43.1

105

145

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

20.9

43.1

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

5.7

42.8

127

229

ZXA00

NOMESCO Finland

Right side

1.7

42.3

1098

7237

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

3.3

41.9

226

718

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

41.7

C43.29

ICD-10 Finland

Malignant melanoma of the outer ear and in the external ear canal other or unspecified histology

+∞

41.7

3016

Kela drug reimbursment

Binimetinib and encorafenib

+∞

41.7

TQB05

NOMESCO Finland

Puncture of skin of trunk

20.3

41.3

D03.9

ICD-10 Finland

Melanoma in situ, unspecified

411.5

41.2

J01DB01

ATC

cefalexin; oral

1.6

40.8

3066

26507

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

40.7

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

+∞

40.7

1513

Kela drug reimbursment

Binimetinib and encorafenib

+∞

40.7

C43.4

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of scalp and neck

+∞

40.7

DAB00

NOMESCO Finland

Excision of lesion of auricle

11.9

40.4

A04AD12

ATC

aprepitant; systemic

401.2

40.1

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

401.2

40.1

A79

ICPC

Malignancy NOS

48.5

39.8

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

+∞

39.6

S29

ICPC

Skin symptom/complaint other

1.9

39.2

664

3798

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

18.4

38.8

8721/3-C44.9

ICD-O-3

Nodular melanoma of skin, NOS

+∞

38.6

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

38.6

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

24.8

38.4

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

380.7

38.1

S21

ICPC

Skin texture symptom/complaint

2.1

37.9

497

2575

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

37.5

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

37.5

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

37.5

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

37.5

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

37.3

309

1287

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

370.5

37.0

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

36.5

D22.4

ICD-10 Finland

Melanocytic naevi of scalp and neck

6.3

35.5

158

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

35.5

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

35.5

I78.1

ICD-10 Finland

Naevus, non-neoplastic

4.3

35.0

134

319

C43.41

ICD-10 Finland

Malignant melanoma of the scalp and neck originating in lentigo maligna

350.0

35.0

ZXA05

NOMESCO Finland

Left side

1.6

34.8

1003

6743

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

51.7

34.4

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

34.4

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

32.5

34.4

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

12.3

34.1

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

65.5

34.0

C43.3

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of other and unspecified parts of face

339.8

33.9

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

15.3

33.9

L03AB04

ATC

interferon alfa-2a; parenteral

45.9

33.7

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

33.4

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

33.4

17261

ICD-8 Finland

Malignant melanoma of skin, Trunk, except scrotum

+∞

33.4

9733

FHL

Excision of skin change in operating room or anesthesia

5.5

33.3

101

188

D23.5

ICD-10 Finland

Benign neoplasm: Skin of trunk

5.1

33.3

107

213

C44

ICD-10 Finland

Other malignant neoplasms of skin

117.6

32.7

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

+∞

32.3

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

32.3

X76

ICPC

Malignant neoplasm breast female

+∞

32.3

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

15.3

32.1

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

16.6

31.9

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

14.0

31.5

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

4.0

31.5

129

328

1725D

ICD-9 Finland

Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,MUU TAI TARK MÄÄR]

+∞

31.3

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

315.1

30.9

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

110.8

30.7

8742/3-C44.3

ICD-O-3

Lentigo maligna melanoma of skin of other and unspecified parts of face

+∞

30.2

8721/3-C44.5

ICD-O-3

Nodular melanoma of skin of trunk

+∞

30.2

Z31.5

ICD-10 Finland

Genetic counselling

3.6

30.0

140

399

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

304.4

29.8

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

304.4

29.8

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

156.1

29.7

TQW40

NOMESCO Finland

Remowal of suture of skin

2.4

29.3

270

1187

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

29.2

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

66.4

28.9

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

28.1

L02BG06

ATC

exemestane; oral

+∞

28.1

L02BG03

ATC

anastrozole; oral

55.4

28.1

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

31.1

28.1

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

11.2

27.5

C43.22

ICD-10 Finland

Malignant melanoma of outer ear and outer ear canal: 'superficial spreading' type

+∞

27.1

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

27.1

B01AB10

ATC

tinzaparin; parenteral

2.7

27.0

189

714

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

4.8

27.0

196

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

62.4

26.9

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.7

26.9

121

335

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.3

26.7

100

235

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

140.9

26.6

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

9.4

26.6

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

19.2

26.5

D23.9

ICD-10 Finland

Benign neoplasm: Skin, unspecified

4.1

26.3

105

262

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

26.2

540

3265

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

26.1

382

2054

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

26.1

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

26.1

ZZS00

NOMESCO Finland

Rotation flap

73.1

25.8

D06BB10

ATC

imiquimod; topical

2.8

25.5

173

642

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

25.2

498

2966

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

25.0

C43.82

ICD-10 Finland

Overall malignant melanoma of the skin: 'superficial spreading' type

+∞

25.0

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

25.0

C43.89

ICD-10 Finland

Overall malignant melanoma of the skin other or unspecified histology

+∞

25.0

Z51.0

ICD-10 Finland

Radiotherapy session

251.6

24.7

C44.60

ICD-10 Finland

Malignant tumor of the skin of the upper extremity including the shoulder without histology

251.6

24.7

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

130.7

24.6

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

3.1

24.3

138

455

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

48.6

24.3

ZX120

NOMESCO Finland

Intravenous

2.1

24.0

272

1318

17271

ICD-8 Finland

Malignant melanoma of skin, Upper limb

+∞

24.0

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

24.0

C43.64

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder acrally

+∞

24.0

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

+∞

24.0

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

5.3

24.0

142

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

67.8

23.8

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

54.3

23.0

ZX050

NOMESCO Finland

Stereotactic radiotherapy

24.8

23.0

PJD51

NOMESCO Finland

Block dissection of cervical lymph nodes

+∞

22.9

QDE00

NOMESCO Finland

Excision of loose skin or fold of skin from lower limb

231.1

22.6

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

231.1

22.6

ZXC20

NOMESCO Finland

Use of chemical agents

4.7

22.6

165

ZQZ00

NOMESCO Finland

Treatment of several skin areas

17.6

22.6

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.7

22.4

153

570

WW500

NOMESCO Finland

Blood transfusion

3.5

22.2

106

309

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

22.0

277

1404

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

21.9

1725A

ICD-9 Finland

Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,MELAN EX LENTIGOMAL]

+∞

21.9

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

21.9

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

21.9

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

+∞

21.9

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

221.0

21.6

ZXC15

NOMESCO Finland

Use of photodynamic technique

6.0

21.4

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

16.3

21.4

5702

FHL

Local lymph node removal (eg armpit, groin)

50.2

21.1

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

12.9

21.1

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

33.9

21.1

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

60.3

20.9

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

+∞

20.8

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

20.8

C43.80

ICD-10 Finland

Overall malignant melanoma of the skin without histology

+∞

20.8

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

20.8

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

20.8

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

20.8

8742/3-C44.5

ICD-O-3

Lentigo maligna melanoma of skin of trunk

+∞

20.8

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

20.8

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

3.1

20.8

114

369

WX002

NOMESCO Finland

Sedation and analgesia

1.5

20.7

701

4820

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

77.2

20.7

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

210.9

20.6

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

6.2

20.4

S79

ICPC

Neoplasm skin benign/unspecified

3.8

20.4

237

TQD05

NOMESCO Finland

Puncture of skin of lower limb

48.2

20.1

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

48.2

20.1

KCD02

NOMESCO Finland

Transurethral resection of bladder

7.2

20.0

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.5

19.9

273

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

19.8

1048

7918

1725B

ICD-9 Finland

Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,SUPERFICIAL SPREAD]

+∞

19.8

1727B

ICD-9 Finland

Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,SUPERFICIAL SPREAD]

+∞

19.8

C43.92

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin: 'superficial spreading' type

+∞

19.8

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

+∞

19.8

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

19.8

L01EC03

ATC

encorafenib; oral

+∞

19.8

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

+∞

19.8

L01XE15

ATC

[U] vemurafenib; oral

+∞

19.8

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

73.8

19.7

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

73.8

19.7

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

105.5

19.6

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

200.8

19.6

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

17.8

19.5

L91.0

ICD-10 Finland

Hypertrophic scar

5.4

19.4

108

F16

ICPC

Eyelid symptom/complaint

2.3

19.3

180

799

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

46.2

19.2

ZXC96

NOMESCO Finland

Robot assisted procedure

7.0

19.1

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

12.8

18.8

L01EE03

ATC

binimetinib; oral

+∞

18.8

L02BX02

ATC

degarelix; parenteral

+∞

18.8

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

18.8

L02BB04

ATC

enzalutamide; oral

+∞

18.8

QBA10

NOMESCO Finland

Incision of skin of trunk

5.3

18.7

109

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

13.4

18.7

Z42.0

ICD-10 Finland

Follow-up care involving plastic surgery of head and neck

30.1

18.3

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

4.1

18.1

176

DHB00

NOMESCO Finland

Excision of lesion of external nose

9.3

18.1

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

18.0

399

2453

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

3.4

18.0

253

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

8.1

17.9

QB5S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in back

52.7

17.9

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

33.0

17.9

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.0

17.9

227

1153

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

10.1

17.8

XKD00

NOMESCO Finland

Uroflowmetry

1.6

17.8

555

3731

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

17.7

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

17.7

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

17.7

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

17.7

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

17.7

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

17.7

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.9

17.7

190

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

95.4

17.6

D23.7

ICD-10 Finland

Benign neoplasm: Skin of lower limb, including hip

5.3

17.5

101

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.8

17.3

110

393

WX702

NOMESCO Finland

Supraglottic ventilation device

2.3

17.3

166

746

QDE20

NOMESCO Finland

Excision and repair of scar or web of skin of lower limb

20.9

17.3

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

17.2

658

4633

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.6

17.2

225

A02BC02

ATC

pantoprazole; systemic

1.3

17.1

2284

19959

L03AA04

ATC

31.6

17.0

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

50.2

17.0

S15

ICPC

Foreign body in skin

2.0

17.0

220

1128

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

16.8

449

2902

S08

ICPC

Skin colour change

2.2

16.8

178

837

D03.4

ICD-10 Finland

Melanoma in situ of scalp and neck

63.5

16.7

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

63.5

16.7

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

16.7

1CD02

NOMESCO Finland

+∞

16.7

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

16.7

C44.70

ICD-10 Finland

Malignant tumor of the skin of the lower extremity including the hip without histology

+∞

16.7

C43.23

ICD-10 Finland

Malignant melanoma of the outer ear and in the outer ear canal nodular

+∞

16.7

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

16.7

C43.09

ICD-10 Finland

Malignant melanoma of the lip other or unspecified histology

+∞

16.7

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

16.7

C43.2

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of ear and external auricular canal

+∞

16.7

1725C

ICD-9 Finland

Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,NODULARE]

+∞

16.7

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

16.7

8721/3-C44.7

ICD-O-3

Nodular melanoma of skin of lower limb and hip

+∞

16.7

C90.0

ICD-10 Finland

Multiple myeloma

170.6

16.5

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

170.6

16.5

E0000UV

ATC

1.4

16.5

1275

10232

D06BX02

ATC

ingenol mebutate; topical

4.1

16.4

159

QDA99

NOMESCO Finland

Other local destruction of skin of lower limb

10.1

16.4

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

5.4

16.1

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

5.9

16.0

WX320

NOMESCO Finland

Spinalanesthesy

1.4

16.0

791

5867

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

8.3

15.7

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

7.3

15.7

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

15.6

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

15.6

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

15.6

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

15.6

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

15.6

C43.91

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin originating in lentigo maligna

+∞

15.6

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

15.6

128

Kela drug reimbursment

Cancers of female genital organs

+∞

15.6

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

85.4

15.6

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

160.5

15.5

A54

ICPC

General and Unspecified, Repair/fix-suture/cast/prosth device

3.7

15.4

178

R4120

NOMESCO Finland

Occupational therapy

1.9

15.4

228

1228

D04.7

ICD-10 Finland

Carcinoma in situ: Skin of lower limb, including hip

9.7

15.1

ELB50

NOMESCO Finland

Total parotidectomy

17.8

15.1

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

15.1

3204

29716

TQW20

NOMESCO Finland

Tatoe

23.4

15.1

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.7

15.0

105

400

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.0

15.0

153

TQW80

NOMESCO Finland

Local dermatologic skincare

2.7

14.9

362

WF099

NOMESCO Finland

Other radiotherapy

15.1

14.8

ZX112

NOMESCO Finland

Subcutaneous

5.6

14.8

TQW40

SPAT

2.4

14.8

125

531

TQC05

NOMESCO Finland

Puncture of skin of upper limb

18.4

14.7

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.9

14.6

152

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

14.6

317

1934

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

14.6

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

+∞

14.6

L01XE41

ATC

[U] binimetinib; oral

+∞

14.6

8091/3-C44.9

ICD-O-3

Superficial basal cell carcinoma of skin, NOS

+∞

14.6

1727D

ICD-9 Finland

Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,MUU TAI TARK MÄÄR]

+∞

14.6

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

14.6

K62.7

ICD-10 Finland

Radiation proctitis

+∞

14.6

8744/3-C44.9

ICD-O-3

Acral melanoma of skin, NOS

+∞

14.6

L01XE46

ATC

[U] encorafenib; oral

+∞

14.6

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

80.3

14.6

C44.40

ICD-10 Finland

Malignant tumor of the skin of the scalp and neck without histology

150.4

14.5

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

150.4

14.5

D23.6

ICD-10 Finland

Benign neoplasm: Skin of upper limb, including shoulder

5.3

14.3

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.8

14.3

340

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.6

14.1

100

386

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

12.0

14.0

QAE20

NOMESCO Finland

Excision and repair of scar or web of skin of head or neck

14.4

14.0

D18.0

ICD-10 Finland

Haemangioma, any site

2.9

14.0

287

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

13.9

162

795

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

12.7

13.9

R50.9

ICD-10 Finland

Fever, unspecified

1.6

13.6

393

2588

L01CA04

ATC

vinorelbine; systemic

+∞

13.5

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

13.5

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

13.5

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

13.5

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

13.5

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

13.5

C43.12

ICD-10 Finland

Malignant melanoma of eyelids including corner of eye: 'superficial spreading' type

+∞

13.5

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

+∞

13.5

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

13.5

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

6.6

13.5

D23.2

ICD-10 Finland

Benign neoplasm: Skin of ear and external auricular canal

4.3

13.5

115

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

140.4

13.4

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.0

13.2

176

911

A06AH03

ATC

naloxegol; oral

8.5

13.2

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.6

13.1

162

UKC02

NOMESCO Finland

Cystoscopy

1.5

13.1

526

3727

D70.82

ICD-10 Finland

Drug-induced neutropenia

8.3

13.0

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

9.3

12.9

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

13.0

12.9

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.9

12.9

135

A98

ICPC

Health maint/preventive medicine

1.5

12.7

3609

34408

JN6CD

NOMESCO Finland

Very extensive CT of torso and neck

32.1

12.6

S04

ICPC

Lump/swelling localized

1.7

12.5

274

1675

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

12.5

C43.93

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin nodular

+∞

12.5

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

12.5

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

12.5

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

12.5

8721/3-C44.6

ICD-O-3

Nodular melanoma of skin of upper limb and shoulder

+∞

12.5

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

12.5

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

12.5

8743/3-C44.4

ICD-O-3

Low cumulative sun damage melanoma of skin of scalp and neck

+∞

12.5

1726B

ICD-9 Finland

Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,SUPERFICIAL SPREAD]

+∞

12.5

C43.19

ICD-10 Finland

Malignant melanoma of eyelids including corner of eye or other unspecified histology

+∞

12.5

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

12.5

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

12.5

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

12.5

L02BX03

ATC

abiraterone; oral

+∞

12.5

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

12.5

ZZS10

NOMESCO Finland

Transposition flap

130.3

12.4

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

12.4

315

2008

Z42.2

ICD-10 Finland

Follow-up care involving plastic surgery of other parts of trunk

21.3

12.0

QCE00

NOMESCO Finland

Excision of loose skin or fold of skin from upper limb

46.8

11.9

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

46.8

11.9

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

10.5

11.7

Z42.4

ICD-10 Finland

Follow-up care involving plastic surgery of lower extremity

12.5

11.6

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

4.7

11.6

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.4

11.6

159

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

6.5

11.5

-54

ICPC

Repair/fix-suture/cast/prosth device

2.4

11.5

382

QWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of skin

7.1

11.5

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

3.4

11.5

160

XX1XN

NOMESCO Finland

Other isotope examination

+∞

11.5

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

+∞

11.5

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

11.5

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

11.5

1726D

ICD-9 Finland

Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,MUU TAI TARK MÄÄR]

+∞

11.5

C44.99

ICD-10 Finland

Unspecified localization of malignant tumor in skin other or unspecified histology

+∞

11.5

WB501

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of primary tumour

+∞

11.5

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

11.5

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

11.5

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

11.5

8070/3-C44.2

ICD-O-3

Squamous cell carcinoma, NOS, of external ear

+∞

11.5

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

11.5

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

6.7

11.4

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.4

11.4

156

G04BE03

ATC

sildenafil; oral

6.0

11.3

R23

ICD-10 Finland

Other skin changes

3.7

11.2

127

XX1XT

NOMESCO Finland

Other puncture with other radiological guidance

12.7

11.1

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.7

10.8

268

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

9.6

10.7

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

7.5

10.6

Z08

ICD-10 Finland

Follow-up examination after treatment for malignant neoplasms

60.1

10.6

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

6.3

10.6

XQ902

NOMESCO Finland

Other photography

7.0

10.5

ZZR30

NOMESCO Finland

Flap of muscle

8.5

10.5

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

8.5

10.5

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.9

10.4

154

831

C43.21

ICD-10 Finland

Malignant melanoma of the outer ear and in the external ear canal originating in lentigo maligna

110.2

10.4

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

10.4

C43.11

ICD-10 Finland

Malignant melanoma of the eyelids including corner of the eye originating in lentigo maligna

+∞

10.4

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

10.4

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

10.4

8743/3-C44.3

ICD-O-3

Low cumulative sun damage melanoma of skin of other and unspecified parts of face

+∞

10.4

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

10.4

1727A

ICD-9 Finland

Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,MELAN EX LENTIGOMAL]

+∞

10.4

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

10.4

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

10.4

1XC18

NOMESCO Finland

+∞

10.4

C43.54

ICD-10 Finland

Malignant melanoma of the torso acral

+∞

10.4

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

+∞

10.4

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

10.4

1727C

ICD-9 Finland

Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,NODULARE]

+∞

10.4

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

10.4

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

4.5

10.2

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

4.9

10.2

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

10.1

709

5534

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

10.0

470

6197

D48

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of other and unspecified sites

9.1

10.0

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

14.6

10.0

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

14.6

10.0

SPAT1211

SPAT

Application of soft bandage

1.6

10.0

289

1905

R23.4

ICD-10 Finland

Changes in skin texture

4.0

10.0

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

40.1

10.0

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

40.1

10.0

C44.20

ICD-10 Finland

Malignant tumor of the skin of the outer ear and of the outer ear canal without histology

40.1

10.0

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.8

9.9

105

S97

ICPC

Chronic ulcer skin

1.7

9.9

193

1144

L02AE04

ATC

triptorelin; parenteral

26.1

9.8

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

4.5

9.7

ELB40

NOMESCO Finland

Partial parotidectomy

3.2

9.7

155

J01MA12

ATC

levofloxacin; systemic

1.4

9.7

549

4140

C44.29

ICD-10 Finland

Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology

55.1

9.6

WF090

NOMESCO Finland

Profylactic radiotherapy

55.1

9.6

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

55.1

9.6

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

4.0

9.6

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.6

9.5

265

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

9.5

448

3268

D04.9

ICD-10 Finland

Carcinoma in situ: Skin, unspecified

10.0

9.5

R22.4

ICD-10 Finland

Localized swelling, mass and lump, lower limb

2.4

9.5

318

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.0

9.5

111

550

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

100.2

9.4

D75

ICPC

Malignant neoplasm colon/rectum

30.1

9.4

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

9.4

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

9.4

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

9.4

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

9.4

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

9.4

C44.19

ICD-10 Finland

Malignant tumor of the skin of the eyelids including corner of the eye or other unspecified histology

+∞

9.4

8720/3-C44.1

ICD-O-3

Malignant melanoma, NOS, of eyelid

+∞

9.4

8720/3-C44.8

ICD-O-3

Malignant melanoma, NOS, of overlapping lesion of skin

+∞

9.4

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

9.4

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

9.4

PXA20

NOMESCO Finland

Extracorporal circulation of lower extremity using heart-lung assist device

+∞

9.4

8742/3-C44.6

ICD-O-3

Lentigo maligna melanoma of skin of upper limb and shoulder

+∞

9.4

8744/3-C44.7

ICD-O-3

Acral melanoma of skin of lower limb and hip

+∞

9.4

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

9.4

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

9.4

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

9.4

3054

Kela drug reimbursment

+∞

9.4

1523

Kela drug reimbursment

+∞

9.4

C44.00

ICD-10 Finland

Malignant tumor of the lip skin without histology

+∞

9.4

8070/3-C44.6

ICD-O-3

Squamous cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

9.4

C43.02

ICD-10 Finland

Malignant melanoma of lip: 'superficial spreading' type

+∞

9.4

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

9.4

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

9.4

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

9.4

384

QBA00

NOMESCO Finland

Puncture of skin of trunk

8.0

9.3

J01MA02

ATC

ciprofloxacin; systemic

1.3

9.2

1260

10738

HA1HA

NOMESCO Finland

Tomosynthesis mammography

13.7

9.2

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.6

9.1

156

2482

ZXB10

NOMESCO Finland

Medial

4.8

9.1

N05AX08

ATC

risperidone; systemic

0.6

9.1

102

1797

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

3.6

9.1

109

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

8.3

9.0

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

3.6

9.0

110

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.7

9.0

100

Z00.0

ICD-10 Finland

General medical examination

1.3

8.9

572

4400

HAE99

NOMESCO Finland

Other reconstruction of breast

12.5

8.8

8720/2-C44.9

ICD-O-3

Melanoma in situ of skin, NOS

12.5

8.8

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

4.8

8.8

9801

FHL

Free skin graft

6.8

8.8

D22.2

ICD-10 Finland

Melanocytic naevi of ear and external auricular canal

10.7

8.8

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

3.8

8.7

D03.2

ICD-10 Finland

Melanoma in situ of ear and external auricular canal

50.1

8.7

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

4.6

8.6

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

8.6

449

ZZF00

NOMESCO Finland

Graft of adipose tissue

8.2

8.6

KEB00

NOMESCO Finland

Biopsy of prostate

4.2

8.5

QBE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of trunk

16.3

8.5

QAE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of head or neck

20.0

8.5

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

5.6

8.4

D03.8

ICD-10 Finland

Melanoma in situ of other sites

90.2

8.4

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

90.2

8.4

C44.79

ICD-10 Finland

Malignant tumor of the skin of the lower extremity including hip or other unspecified histology

90.2

8.4

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

3.0

8.4

155

QAE00

NOMESCO Finland

Excision of loose skin or fold of skin from head and neck

6.7

8.3

C43.10

ICD-10 Finland

Malignant melanoma of eyelids including corner of eye without histology

+∞

8.3

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

8.3

KE002

NOMESCO Finland

Radical radiotherapy of prostata and seminal vesicles

+∞

8.3

WC325

NOMESCO Finland

Demanding therapy of local tumor recidive with biomodifiers

+∞

8.3

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

8.3

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

8.3

C43.8

ICD-10 Finland

Malignant neoplasm: Overlapping malignant melanoma of skin

+∞

8.3

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

8.3

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

8.3

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

8.3

C43.81

ICD-10 Finland

Overall malignant melanoma of the skin originating in lentigo maligna

+∞

8.3

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

+∞

8.3

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

8.3

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

8.3

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

8.3

8720/3-C80.9

ICD-O-3

Malignant melanoma, NOS, of unknown primary site

+∞

8.3

PJ003

NOMESCO Finland

Adjuvant radiotherapy of neck, clavicle and axilla

+∞

8.3

C49.29

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor

+∞

8.3

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

8.3

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

8.5

8.3

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.5

8.3

252

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

5.8

8.3

GD1AD

NOMESCO Finland

Thorax CT examination

1.9

8.2

114

604

S59

ICPC

Skin, Other therap proced/minor surg NEC

2.9

8.2

161

JFF23

NOMESCO Finland

Transversostomy

6.0

8.1

QDA10

NOMESCO Finland

Incision of skin of lower limb

3.6

8.1

XW000

NOMESCO Finland

Bone marrow biopsy

2.0

8.1

489

QB3S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in abdomen

17.2

8.1

QCE20

NOMESCO Finland

Excision and repair of scar or web of skin of upper limb

11.7

8.1

ZZR10

NOMESCO Finland

Flap of skin and muscle

10.0

8.0

XJH00

NOMESCO Finland

Transanal ultrasonography

1.6

8.0

185

1152

QBE99

SPAT

4.6

8.0

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.2

8.0

346

R60.0

ICD-10 Finland

Localized oedema

1.4

7.9

346

2491

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

5.4

7.8

D01AE16

ATC

amorolfine; topical

1.4

7.7

375

2750

HAB99

NOMESCO Finland

Other partial excision of mammary gland

3.8

7.7

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

45.0

7.7

XX1AD

NOMESCO Finland

Other CT-examination

45.0

7.7

KFC10

NOMESCO Finland

Bilateral orchiectomy

45.0

7.7

TQX00

NOMESCO Finland

Needle biopsy of skin

15.0

7.7

Q82.58

ICD-10 Finland

Congenital non-neoplastic naevus

3.6

7.6

-59

ICPC

Other therap proced/minor surg NEC

2.0

7.6

451

D04.8

ICD-10 Finland

Carcinoma in situ: Skin of other sites

25.0

7.6

L72.1

ICD-10 Finland

Trichilemmal cyst

1.6

7.5

174

1086

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.8

7.5

608

7473

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

7.4

212

1394

C44.90

ICD-10 Finland

Unspecified localization of malignant tumor of the skin without histology

80.2

7.4

C49.20

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology

80.2

7.4

OAA41

NOMESCO Finland

Health check based on individual needs

80.2

7.4

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.6

7.4

205

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

+∞

7.3

1XC17

NOMESCO Finland

+∞

7.3

4CJ01

NOMESCO Finland

+∞

7.3

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

7.3

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

7.3

C49.39

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor

+∞

7.3

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

7.3

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

+∞

7.3

QA3S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in ear

+∞

7.3

PJ5SN

NOMESCO Finland

Sentinell SPECT with low dose CT

+∞

7.3

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

+∞

7.3

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

+∞

7.3

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

7.3

8721/3-C44.3

ICD-O-3

Nodular melanoma of skin of other and unspecified parts of face

+∞

7.3

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

7.3

C44.02

ICD-10 Finland

Spinocellular carcinoma of the lip skin

+∞

7.3

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

7.3

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

7.3

8070/3-C00.1

ICD-O-3

Squamous cell carcinoma, NOS, of external lower lip

+∞

7.3

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

7.3

1726A

ICD-9 Finland

Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,MELAN EX LENTIGOMAL]

+∞

7.3

1888X

ICD-9 Finland

Malignant neoplasm of bladder, Other specified sites of bladder

+∞

7.3

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

7.3

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

7.3

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

7.3

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

+∞

7.3

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

7.3

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

7.3

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

7.3

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

7.3

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

7.3

G04BE09

ATC

vardenafil; oral

+∞

7.3

L04AX04

ATC

lenalidomide; oral

+∞

7.3

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

+∞

7.3

8070/3-C44.4

ICD-O-3

Squamous cell carcinoma, NOS, of skin of scalp and neck

+∞

7.3

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

7.3

D23

ICD-10 Finland

Other benign neoplasms of skin

2.4

7.3

244

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.5

7.3

253

1739

JG1BG

NOMESCO Finland

MRI of rectum

15.7

7.2

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

15.7

7.2

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

3.2

7.2

110

QX4YT

NOMESCO Finland

Puncture of superficial collection under ultrasound guidance

7.3

7.2

M05BX04

ATC

denosumab; parenteral

1.8

7.2

110

610

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.0

7.1

456

HA1SA

NOMESCO Finland

Expansion mammography

30.0

7.1

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

4.4

7.1

R22.3

ICD-10 Finland

Localized swelling, mass and lump, upper limb

2.4

7.1

223

KAC10

NOMESCO Finland

Total nephrectomy with capsule

12.0

7.1

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

7.0

1355

11897

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.8

7.0

151

TNG34

NOMESCO Finland

Major custom moulded orthopaedic cast, knee or lower leg

2.7

6.9

169

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.0

6.9

432

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

6.9

571

7002

WVA20

NOMESCO Finland

Medicine administration

2.3

6.8

273

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

6.8

176

1130

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

6.8

252

1759

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

9.3

6.8

WX400

NOMESCO Finland

Inhalation anesthesy

1.8

6.8

102

560

NK1AT

NOMESCO Finland

Muscle biopsy with ultrasound guidance

6.1

6.8

HA4ST

NOMESCO Finland

Labeling mammary gland pathology with sterotactic guidance

40.1

6.8

NFR30

NOMESCO Finland

Extended excision of soft tissue tumour of hip or thigh

40.1

6.8

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

40.1

6.8

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

40.1

6.8

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

40.1

6.8

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

3.2

6.7

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

16.7

6.7

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

0.5

6.7

1017

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.4

6.7

211

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

22.5

6.7

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

6.4

6.6

KC1GB

NOMESCO Finland

Cystography with X-ray

7.8

6.6

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

6.6

217

1479

PJW99

NOMESCO Finland

Other operation on lymphatic system

69.9

6.4

329

Kela drug reimbursment

Lenalidomide

69.9

6.4

153

Kela drug reimbursment

Lenalidomid

69.9

6.4

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

69.9

6.4

CBB30

NOMESCO Finland

Excision of lesion of eyelid

2.0

6.4

390

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

3.5

6.4

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

6.4

524

4172

B01AB04

ATC

dalteparin; parenteral

1.7

6.3

134

818

TDA10

NOMESCO Finland

Needle biopsy of auricle or external auditory canal

6.5

6.3

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

9.2

6.3

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

6.3

267

1915

JG1CG

NOMESCO Finland

Extensive MRI of rectum

18.0

6.3

7323

FHL

Electrosection of TU bladder wall change

18.0

6.3

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

6.2

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

6.2

8721/3-C44.4

ICD-O-3

Nodular melanoma of skin of scalp and neck

+∞

6.2

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

6.2

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

+∞

6.2

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

6.2

8743/3-C44.2

ICD-O-3

Low cumulative sun damage melanoma of external ear

+∞

6.2

17241

ICD-8 Finland

Malignant melanoma of skin, Scalp and neck

+∞

6.2

C03.1

ICD-10 Finland

Malignant neoplasm: Lower gum

+∞

6.2

C07.70

ICD-10 Finland

Malignant tumor of the superficial part of the parotid gland

+∞

6.2

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

+∞

6.2

1726C

ICD-9 Finland

Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,NODULARE]

+∞

6.2

8090/3-C44.0

ICD-O-3

Basal cell carcinoma, NOS, of skin of lip, NOS

+∞

6.2

8070/3-C44.5

ICD-O-3

Squamous cell carcinoma, NOS, of skin of trunk

+∞

6.2

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

+∞

6.2

L03AB01

ATC

interferon alfa natural; parenteral

+∞

6.2

C79.0

ICD-10 Finland

Secondary malignant neoplasm of kidney and renal pelvis

+∞

6.2

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

+∞

6.2

C43.94

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin acrally

+∞

6.2

C67

ICD-10 Finland

Malignant neoplasm of bladder

+∞

6.2

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

6.2

C49.30

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the thorax without histology

+∞

6.2

C71.23

ICD-10 Finland

Malignant tumor of temporal lobe grade IV glioma

+∞

6.2

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

+∞

6.2

C43.83

ICD-10 Finland

Overall malignant melanoma of the skin nodular

+∞

6.2

C69.32

ICD-10 Finland

Malignant tumor of the chorioidea melanoma

+∞

6.2

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

6.2

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

6.2

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

6.2

189

Kela drug reimbursment

Imatinib

+∞

6.2

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

6.2

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

+∞

6.2

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

6.2

C43.1

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of eyelid, including canthus

+∞

6.2

R03BB04

ATC

tiotropium bromide; inhalant

0.7

6.2

171

2468

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

6.2

213

1463

D03.30

ICD-10 Finland

Melanoma in situ on the lip

26.7

6.2

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

0.5

6.2

967

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

6.2

776

6506

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

4.1

6.2

F03

ICD-10 Finland

Unspecified dementia

0.5

6.2

974

H02AB09

ATC

hydrocortisone; systemic

2.1

6.1

308

B07.9

ICD-10 Finland

Verruca simplex

1.9

6.1

457

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

12.5

6.1

QXE99

NOMESCO Finland

Other excision or repair of unspecified region of skin

12.5

6.1

SPAT1058

SPAT

PEF monitoring instruction

0.6

6.0

125

1904

QC9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in upper extremities, unspecified

10.0

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1536

4625

4.14

307.65

7.9

2.7

241.5

239.8

u/l

0.10

1492

4265

(3002256) Pathology report gross observation

2115

3642

8.50

307.65

1.8

1.1

—

(40768804) Tissue Pathology biopsy report

4149

14899

7.04

307.65

3.8

1.7

—

(4035726)

1552

1357

15.17

307.65

1.5

1.2

—

(40768795) Lymph node Pathology biopsy report

189

20.74

248.70

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

298

396

7.87

211.88

1.8

1.3

—

(40768443) Skin Pathology biopsy report

674

1937

3.80

201.04

1.3

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3283

22403

2.05

153.68

9.1

3.8

11.6

12.0

umol/l

1.01

3155

20910

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

706

2503

3.07

149.00

3.6

1.4

12.8

8.6

ug/l

0.27

547

1865

(3044640) Blood type and Crossmatch panel - Blood

2183

13115

2.06

142.47

2.5

2.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2947

19841

1.97

137.65

4.0

3.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

3444

24627

1.96

132.81

11.7

6.3

4.1

4.3

e9/l

6.74

3022

21087

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

286

604

4.93

126.77

1.3

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

846

3723

2.49

115.93

6.8

1.8

374.5

366.2

nmol/l

0.63

810

3355

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4373

35169

1.95

104.64

10.6

5.4

79.8

76.1

u/l

4.93

4141

32487

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1673

10015

1.94

103.49

2.4

2.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

305

802

3.96

101.79

1.4

1.3

14.4

10.0

u/l

4.84

252

634

(3033658) Prothrombin time (PT) actual/Normal

1761

10788

1.90

101.15

4.1

3.5

88.1

86.6

1.57

1735

10491

(3015377) Calcium [Moles/volume] in Serum or Plasma

2197

14643

1.80

94.82

5.5

2.1

2.4

mmol/l

2.23

1934

12168

(40768793) Breast Pathology biopsy report

154

261

6.03

86.80

1.3

1.2

—

(42870588) Differential panel, method unspecified - Blood

2198

15012

1.74

84.69

7.1

5.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

27.75

81.12

1.1

1.0

1.7

1.3

ug/l

—

(40758558) Short blood count panel - Blood

1638

10393

1.80

80.69

9.2

4.7

—

(3006315) Basophils [#/volume] in Blood

2971

22468

1.65

74.98

7.0

5.4

0.0

e9/l

0.55

2528

19217

(3001604) Monocytes [#/volume] in Blood

2949

22319

1.64

73.71

7.1

5.4

0.6

e9/l

3.51

2513

19070

(3024561) Albumin [Mass/volume] in Serum or Plasma

2633

19413

1.64

72.69

6.0

3.8

35.3

35.5

g/l

1.32

2474

17710

(40768800) Prostate Pathology biopsy report

165

351

4.81

72.33

1.2

1.1

—

(3013115) Eosinophils [#/volume] in Blood

3036

23232

1.63

71.90

7.2

5.5

0.2

e9/l

2.70

2624

20168

(3019198) Lymphocytes [#/volume] in Blood

3003

22929

1.63

71.66

7.1

5.4

2.0

1.8

e9/l

1.35

2605

19956

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

16.37

71.04

6.5

1.2

—

(3022096) Basophils/100 leukocytes in Blood

2699

20107

1.63

70.87

7.3

5.6

0.7

1.19

2512

18471

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2799

21066

1.63

70.31

6.4

5.3

1.2

mmol/l

1.05

2553

18614

(3019069) Monocytes/100 leukocytes in Blood

2768

20839

1.62

68.97

7.5

5.9

8.7

0.24

2591

19208

(3006504) Eosinophils/100 leukocytes in Blood

2750

20711

1.62

68.12

7.3

5.6

2.9

3.0

0.29

2560

19002

(3002030) Lymphocytes/100 leukocytes in Blood

2810

21303

1.61

67.51

7.4

5.7

27.1

27.2

0.16

2616

19517

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3017

23379

1.60

65.27

6.9

5.7

1.2

mmol/l

1.82

2532

19588

(3018010) Neutrophils/100 leukocytes in Blood

2762

21095

1.58

62.57

7.1

5.6

57.7

57.9

0.26

2578

19440

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1315

8352

1.74

61.97

4.7

2.2

2.5

2.4

mmol/l

3.00

1170

7132

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1112

6756

1.80

61.00

3.5

2.5

0.8

mmol/l

0.14

1032

6180

(3018418) pH of Serum or Plasma

1914

13513

1.62

59.70

4.9

3.3

7.4

0.07

364

2350

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

263

889

3.05

59.11

3.1

1.9

1601.9

97.9

u/ml

0.83

232

708

(3013826) Glucose [Moles/volume] in Serum or Plasma

3422

27850

1.55

55.69

5.6

4.4

6.7

6.8

mmol/l

2.73

3271

25958

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4921

43761

1.76

54.51

18.3

12.4

76.3

76.5

ml/min/173m2

0.30

4284

35399

(3021589) Normoblasts [#/volume] in Blood

2560

19837

1.51

50.40

11.4

8.7

0.0

e9/l

0.15

2089

16196

(3023368) Bacteria identified in Blood by Culture

1715

12582

1.51

41.81

4.3

3.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

5297

48922

1.82

41.42

21.1

16.4

139.7

139.8

mmol/l

0.66

5196

47586

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

8.73

41.35

1.2

1.1

—

(3032080) INR in Blood by Coagulation assay

2480

19611

1.46

41.32

10.1

10.6

1.3

inr

0.81

675

5421

(3023103) Potassium [Moles/volume] in Serum or Plasma

5306

49054

1.83

41.01

21.3

16.5

4.0

mmol/l

6.16

5196

47629

(3003694) ABO and Rh group [Type] in Blood

1524

10968

1.53

40.43

1.4

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

146

5.40

39.65

5.5

1.1

117.0

132.5

u/ml

0.07

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5069

46383

1.67

39.20

18.2

13.5

25.4

24.0

mg/l

2.08

4206

36441

(3042936) Bacteria identified in Isolate by Culture

966

6312

1.63

38.77

2.0

—

(36304419) Bacteria [Presence] in Urine

1661

12302

1.49

37.91

3.6

2.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

279

1217

2.36

37.72

1.3

27.6

32.0

iu/l

1.37

228

1052

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

133

393

3.44

37.33

1.6

1.3

32.9

31.7

u/l

0.13

125

287

(3007853) Bacteria identified in Skin by Aerobe culture

836

5343

1.66

36.44

1.9

1.8

—

(3030467) Casts [#/volume] in Urine by Automated count

1709

12810

1.47

36.43

3.7

3.0

0.4

0.5

e6/l

0.66

1300

9548

(3021387) Prolactin [Units/volume] in Serum or Plasma

232

948

2.51

36.21

1.8

1.7

292.6

298.2

mu/l

0.11

218

856

(3018095) Leukocytes [#/volume] in Urine

2084

16251

1.44

35.91

4.1

3.5

92.0

111.1

e6/l

0.51

1513

11422

(3031040) Bacteria [#/volume] in Urine by Automated count

3574

30668

1.42

35.74

4.5

4.4

715.9

1971.0

e6/l

1.41

466

(3002582) Erythrocytes [#/volume] in Urine

1822

13904

1.45

35.08

3.7

3.1

114.1

103.3

e6/l

0.08

1412

10555

(3017446) Testosterone [Moles/volume] in Serum or Plasma

491

2736

1.87

34.50

2.0

2.2

11.5

14.4

nmol/l

10.38

432

2368

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

632

3833

1.73

33.35

3.0

2.2

34.5

50.1

u/l

0.65

559

3235

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

235

1009

2.38

32.93

1.5

1.8

3.7

4.6

iu/l

0.43

334

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1880

14613

1.42

32.06

4.8

2.3

58.0

59.4

u/l

0.68

1732

13377

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5307

49621

1.70

32.03

13.9

9.3

25.4

25.5

u/l

0.06

5144

47438

(40761511) CBC panel - Blood by Automated count

5177

48143

1.62

31.39

16.3

13.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

20.99

30.29

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

7.46

30.09

11.4

1.5

63.5

44.1

u/l

0.46

(3007461) Platelets [#/volume] in Blood

5444

51434

1.78

29.37

27.3

19.9

244.9

244.7

e9/l

0.08

5336

49837

(3024731) MCV [Entitic volume]

5444

51452

1.77

29.09

27.2

19.8

91.2

91.4

2.37

5380

50504

(3026361) Erythrocytes [#/volume] in Blood

5444

51457

1.77

29.01

27.3

19.9

4.5

e12/l

3.25

5329

49667

(3000963) Hemoglobin [Mass/volume] in Blood

5444

51465

1.77

28.88

27.4

20.0

134.3

135.9

g/l

12.71

5385

50528

(3035941) MCH [Entitic mass]

5442

51453

1.76

28.69

27.1

19.8

30.3

30.4

4.78

5378

50506

(3010813) Leukocytes [#/volume] in Blood

5442

51468

1.76

28.46

27.3

19.9

6.8

e9/l

0.66

5321

49674

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

552

3401

1.69

27.27

2.0

0.2

g/l

2.89

518

3090

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1015

7216

1.49

27.06

3.3

2.7

1.8

2.5

e6/l

2.34

557

3922

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

669

4352

1.61

26.64

1.6

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

270

1347

2.05

26.14

2.2

1.5

37.6

25.5

u/ml

0.61

261

1278

(3021879) Hepatitis B virus core Ab [Presence] in Serum

402

2295

1.81

25.97

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

586

3723

1.64

25.66

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

4163

37530

1.37

25.64

22.4

16.1

13.8

13.7

4.29

4108

36583

(3014576) Chloride [Moles/volume] in Serum or Plasma

839

5794

1.52

25.60

7.3

6.4

104.3

mmol/l

0.08

828

5648

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

699

4679

1.56

24.52

2.8

2.2

9.4

8.0

umol/l

0.85

618

4024

(3003458) Phosphate [Moles/volume] in Serum or Plasma

837

5847

1.50

24.07

6.6

5.5

1.0

mmol/l

0.23

786

5352

(3044889) 12 lead EKG panel

3771

33618

1.34

24.06

4.5

4.0

—

(3026782) Osmolality of Urine

1189

8910

1.42

23.65

3.1

2.7

549.9

550.3

mosm/kgh2o

0.02

1019

7426

(3000850) Epithelial cells [#/volume] in Urine

1277

9712

1.40

23.28

2.9

2.5

4.5

4.8

e6/l

0.35

1120

8372

(3014111) Lactate [Moles/volume] in Serum or Plasma

613

4048

1.57

22.75

6.0

6.5

1.4

mmol/l

0.20

587

3893

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

693

4726

1.53

22.23

3.7

3.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3951

35635

1.33

22.22

4.9

3.9

15.0

14.9

pmol/l

1.56

3580

32049

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1067

7928

1.42

22.09

3.2

2.6

1.8

1.2

e6/l

0.62

607

4599

(3037467) Urinalysis macro (dipstick) panel - Urine

3620

32337

1.31

21.29

4.4

4.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1275

9837

1.38

21.03

4.9

4.0

161.5

518.3

ng/l

8.00

1057

8079

(3049717) Cytology report of Urine Cyto stain

290

1598

1.86

21.00

2.7

1.8

—

(3000991) Gas panel - Venous blood

568

3757

1.57

20.86

8.0

7.9

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1732

14024

1.33

20.80

3.8

2.6

31.5

34.2

u/l

1.15

1631

13184

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

145

627

2.35

20.10

4.7

5.4

378.1

723.8

iu/ml

0.49

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

6.38

20.07

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

610

4151

1.52

19.66

7.2

7.0

10.5

11.0

mmol/l

1.01

586

3915

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

380

2336

1.67

18.81

7.8

9.0

24.4

mmol/l

0.05

359

2129

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

235

3.18

18.68

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4647

43305

1.35

18.47

5.9

4.7

2.0

2.1

mu/l

1.22

4229

39223

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

394

2460

1.64

18.36

4.0

3.0

4.4

pmol/l

0.73

366

2132

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

114

469

2.46

17.69

2.7

2.5

671.4

509.4

u/ml

—

(3009542) Hematocrit [Volume Fraction] of Blood

4422

41024

1.31

17.35

19.8

14.9

39.7

39.5

0.79

3056

27161

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

191

3.32

17.17

2.5

1.9

497.8

712.3

e6/l

1.32

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

437

2859

1.57

16.77

1.6

—

(21494815) CD4 cells/100 lymphocytes in Specimen

212

3.14

16.39

1.7

2.1

36.2

44.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

125

561

2.25

15.97

3.6

2.8

1.1

1.3

0.31

418

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1000

7748

1.35

15.50

1.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1864

15727

1.27

15.34

3.0

3.1

1547.1

1540.1

ng/l

0.02

1621

13536

(40768441) Liver Pathology biopsy report

181

3.23

15.13

1.1

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

294

1790

1.68

15.11

2.5

2.3

299.4

661.2

ug/l

1.97

281

1689

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

396

2603

1.56

14.87

1.3

1.2

124.1

134.1

iu/ml

0.17

103

994

(40760892) CBC W Ordered Manual Differential panel - Blood

1170

9361

1.31

14.41

5.0

4.2

—

(40768806) Pleura Pathology biopsy report

361

2.49

14.32

1.9

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

118

543

2.20

14.23

3.5

1.9

113.0

531.8

u/ml

0.78

109

495

(46235355) HIV 1 and 2 tests - Meaningful Use set

694

5148

1.39

14.03

1.7

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

151

768

1.99

14.00

3.8

3.6

57.3

58.6

0.58

151

768

(3018677) aPTT in Platelet poor plasma by Coagulation assay

937

7324

1.33

13.53

2.0

1.9

30.3

30.0

0.87

902

7086

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1299

10637

1.28

13.27

3.5

2.8

0.8

0.7

ug/l

0.99

973

7401

(3045142) Bone marrow Pathology biopsy report

334

2.48

13.11

1.3

1.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

3798

35099

1.23

12.53

4.1

4.2

12.6

12.4

mm/h

0.34

3484

32248

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

246

1506

1.66

12.43

2.3

3.0

0.4

0.3

u/ml

0.64

142

869

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4880

46452

1.30

12.15

5.3

4.9

6.0

mmol/l

3.37

4404

42039

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

343

2.38

11.94

1.9

1.8

108.6

465.1

u/ml

0.43

330

(3022145) Colonoscopy Study observation

627

4708

1.37

11.70

1.3

—

(40765096) Chromosome analysis panel by Banding

4.46

11.64

1.1

1.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2191

19258

1.22

11.55

2.2

79.5

78.7

nmol/l

0.60

1928

16897

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1840

15900

1.23

11.44

2.4

2.2

178.5

235.4

u/l

2.68

1747

14829

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

121

613

1.99

11.42

1.1

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

252

2.56

11.04

1.6

1.9

—

(3003434) Protein [Mass/volume] in Pleural fluid

106

520

2.06

10.95

1.7

1.5

31.3

28.8

g/l

1.38

454

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

183

1072

1.73

10.93

2.1

2.2

3.6

g/l

0.12

177

1007

(3052851) Hemolysis interference index of Serum or Plasma

218

1343

1.65

10.79

3.5

3.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

398

2.20

10.75

4.3

3.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

418

2.17

10.72

1.6

1.5

75143.0

63592.3

e6/l

0.15

247

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

811

6409

1.31

10.66

2.9

2.7

22.6

22.5

0.07

709

5351

(3000494) Fungus identified in Specimen by Culture

684

5281

1.33

10.61

1.5

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

466

2.10

10.60

1.6

1.5

1636.5

2855.3

e6/l

1.01

344

(3013512) EKG study

1694

14612

1.22

10.53

4.5

4.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

146

3.03

10.47

2.9

2.2

32.7

43.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

177

1043

1.72

10.37

2.3

2.2

196.9

190.4

0.39

169

991

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

188

1129

1.69

10.28

1.9

93.7

90.6

0.93

177

1057

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

206

1268

1.65

10.25

1.6

1.7

—

(3003396) Base excess in Arterial blood by calculation

693

5393

1.32

10.16

6.2

6.9

0.8

1.3

mmol/l

2.20

557

4139

(3027801) Oxygen [Partial pressure] in Arterial blood

696

5428

1.32

10.04

6.2

6.9

12.9

11.6

kpa

7.34

666

5149

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

696

5431

1.32

10.00

6.2

6.9

5.0

5.1

kpa

0.21

667

5167

(3012441) Differential panel - Pleural fluid

391

2.16

9.98

1.7

1.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

858

6889

1.29

9.96

2.7

2.6

2.3

g/l

1.46

798

6314

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

124

671

1.87

9.69

1.5

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

5.29

9.62

1.0

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

252

2.44

9.57

1.2

1.3

9.6

11.9

u/l

1.05

224

(3017181) Myelocytes/100 leukocytes in Blood

483

3594

1.37

9.51

4.3

3.7

1.0

0.7

1.28

150

779

(3036489) Thrombin time

232

1500

1.57

9.45

1.8

21.2

0.03

211

1313

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

320

2219

1.47

9.37

5.0

4.1

24.1

24.2

mmol/l

0.19

294

1962

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2134

18979

1.20

9.37

5.8

4.0

3.5

2.4

ug/l

1.43

1899

16989

(3017354) Segmented neutrophils/100 leukocytes in Blood

369

2.16

9.33

3.4

2.6

56.1

59.1

0.41

236

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

146

842

1.75

9.27

1.6

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1512

13033

1.22

9.24

3.0

2.5

5088.0

5827.3

umol/l

0.26

1310

11083

(3027945) Reticulocytes/100 erythrocytes in Blood

695

5490

1.30

9.11

2.6

2.1

1.8

1.7

1.07

620

4757

(3010370) Gastrin [Moles/volume] in Serum or Plasma

4.88

8.82

3.4

1.4

72.0

28.5

pmol/l

0.58

(40758292) HTLV I+II Ab panel - Serum

5.73

8.79

1.2

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

570

4402

1.33

8.79

7.0

7.7

120.3

122.6

g/l

2.02

552

4229

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

682

5406

1.30

8.70

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

683

5425

1.29

8.57

1.7

—

(3026008) Bacteria identified in Urine by Culture

1621

14155

1.20

8.53

3.0

3.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

459

3458

1.36

8.37

4.4

3.8

0.1

0.54

141

726

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

8.33

1.1

0.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

116

648

1.81

8.25

1.7

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

491

3745

1.34

8.25

4.9

3.0

1.2

mmol/l

0.28

435

3155

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

108

597

1.82

7.97

1.5

1.4

120.1

126.1

u/ml

0.18

111

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

199

1295

1.56

7.94

1.2

—

(4281824)

237

2.33

7.93

1.1

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

437

3297

1.35

7.90

4.0

3.6

0.5

0.02

111

585

(3020630) Protein [Mass/volume] in Serum or Plasma

513

3965

1.32

7.87

2.8

1.6

65.9

66.7

g/l

1.62

459

3513

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2175

19590

1.17

7.84

4.2

3.9

44.8

85.7

ng/l

1.51

1639

14127

(3042111) Morphology [Interpretation] in Bone marrow Narrative

109

608

1.81

7.82

1.4

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

527

4094

1.32

7.80

2.8

2.2

69.9

68.5

e9/l

0.39

373

3118

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

421

3165

1.36

7.79

1.5

1.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

874

7237

1.24

7.72

27.7

28.9

1.3

1.5

inr

1.12

966

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

315

2262

1.41

7.69

1.7

1.6

1.5

g/l

0.76

275

1926

(3014765) Yersinia sp identified in Stool by Organism specific culture

199

1306

1.54

7.66

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

277

1948

1.44

7.59

2.1

1.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

199

1314

1.53

7.46

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

900

7506

1.23

7.43

2.7

2.6

12.6

12.9

umol/l

0.50

838

6874

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.86

7.40

1.3

1.1

—

(3016502) Oxygen saturation in Arterial blood

612

4887

1.28

7.35

6.6

7.2

96.2

95.1

6.22

591

4689

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1723

15291

1.18

7.32

4.8

3.9

22.2

24.2

7.16

940

7585

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

278

2.17

7.32

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

256

1798

1.44

7.09

1.8

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

446

1.90

7.08

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

154

973

1.60

7.02

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

291

2.11

6.93

2.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

5.43

6.76

1.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2713

25076

1.15

6.57

2.5

2.6

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.16

6.54

1.2

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.16

6.54

1.2

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.16

6.54

1.2

1.0

—

(40761536) Microorganisms panel - Urine sediment

467

3663

1.30

6.45

4.6

4.0

—

(3024869) Neuronal Ab [Presence] in Serum

3.13

6.42

1.2

1.1

—

(3025159) Blasts/100 leukocytes in Blood

424

3286

1.31

6.40

4.3

3.9

0.1

0.3

0.50

117

633

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

274

2.09

6.38

1.4

12.9

13.2

u/l

0.10

264

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

342

1.97

6.37

1.4

1.3

422.6

309.7

u/l

0.78

324

(3045788) Cell count panel - Pleural fluid

364

1.93

6.32

1.7

1.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

468

3683

1.29

6.31

4.2

3.8

104.4

95.8

ng/l

0.83

404

3093

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.45

6.27

1.2

1.0

—

(3019225) pH of Specimen

593

4810

1.26

6.26

4.5

3.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1155

10031

1.19

6.19

1.6

1.7

1.5

1.2

mg/l

0.87

901

7691

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

193

1320

1.48

6.18

2.2

1.5

0.0

g/l

0.00

170

1207

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

216

1511

1.45

6.16

2.3

3.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

196

1346

1.47

6.15

2.1

1.5

0.0

g/l

0.50

170

1213

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2080

18957

1.15

5.96

3.0

2.9

147.1

129.7

ug/l

1.66

1897

17334

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3082

28854

1.14

5.96

3.1

3.0

51.2

47.7

u/l

1.09

2841

26396

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

141

910

1.56

5.94

1.7

1.4

—

(3047189) Immunofixation for 24 hour Urine

179

2.30

5.83

1.3

1.1

—

(3051651) Icteric interference index of Serum or Plasma

211

2.19

5.83

5.0

3.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

360

2769

1.32

5.76

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

406

1.83

5.71

1.8

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

106

647

1.65

5.63

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

226

1622

1.41

5.63

2.3

1.5

1.1

0.5

g/l

1.27

185

1375

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

205

1447

1.43

5.60

2.1

1.5

0.0

g/l

1.09

179

1311

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.80

5.55

1.1

1.3

17.5

89.0

ug/l

0.84

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

143

941

1.53

5.55

1.6

1.4

—

(3035880) pH of Pleural fluid

209

2.16

5.55

1.2

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

190

1326

1.45

5.53

1.3

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2320

21386

1.14

5.51

2.1

94.2

94.4

pmol/l

0.07

1211

11063

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

108

667

1.63

5.49

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

378

2953

1.30

5.42

2.8

2.3

10.1

10.8

g/l

1.90

344

2688

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

437

1.77

5.35

1.2

50.1

57.2

u/l

0.51

273

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

313

2387

1.33

5.34

8.6

9.7

—

(3036603) Volume of Urine

281

1.97

5.29

1.6

1.4

1828.5

1917.4

—

(3051611) Lipemic interference index of Serum or Plasma

439

1.76

5.27

4.2

3.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

248

1832

1.37

5.23

2.3

1.5

3.1

3.0

g/l

0.04

183

1407

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

132

2.43

5.19

4.0

2.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

592

1.65

5.19

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4931

47903

1.18

5.15

5.3

2.7

mmol/l

0.03

4451

43933

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

212

1535

1.40

5.06

2.1

1.4

38.1

37.6

g/l

0.70

176

1287

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1373

12270

1.16

5.03

2.2

2.3

3.0

2.9

mg/l

0.40

1176

10395

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4789

46437

1.17

5.01

4.7

1.5

1.4

mmol/l

0.08

4325

42493

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

141

2.35

4.98

2.6

2.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4619

44675

1.16

4.96

6.3

6.4

40.1

40.6

mmol/mol

2.87

4195

41081

(3037756) Immunofixation for Serum or Plasma

139

934

1.50

4.94

1.5

1.2

—

(3011412) CD3 cells [#/volume] in Blood

247

1.99

4.92

2.7

2.1

1.1

1.0

e9/l

0.28

144

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

124

2.43

4.87

2.8

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

181

2.16

4.86

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

181

2.16

4.86

1.3

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

259

1951

1.34

4.84

2.3

1.4

3.5

3.9

g/l

4.46

183

1377

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

259

1953

1.34

4.81

2.3

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

182

2.15

4.80

1.8

2.0

17.8

16.2

0.20

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

125

2.41

4.79

2.8

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

125

2.41

4.79

2.8

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

259

1955

1.34

4.78

2.3

1.4

7.2

7.5

g/l

1.88

186

1431

(3023410) Appearance of Cerebral spinal fluid

393

1.76

4.78

1.2

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

243

1819

1.35

4.74

2.3

1.5

9.6

10.4

g/l

1.74

193

1509

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4637

44903

1.15

4.73

4.2

1.3

mmol/l

0.06

4144

40737

(1616796) Gas panel - Central venous blood

147

1009

1.47

4.72

3.3

3.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4818

46798

1.16

4.67

4.7

4.6

mmol/l

0.11

4381

43109

(3048929) Epstein Barr virus Ab [Presence] in Serum

133

898

1.49

4.64

1.2

—

(3010503) CD19 cells [#/volume] in Blood

159

2.21

4.61

2.6

2.2

0.2

0.1

e9/l

0.34

152

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

604

1.60

4.60

1.3

1.2

243.4

280.2

u/ml

0.79

383

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

152

1057

1.45

4.57

3.8

2.6

1.7

mg/l

0.04

142

936

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

370

1.77

4.53

1.9

1.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

187

2.09

4.50

1.9

2.0

67.0

72.1

0.88

176

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

640

5431

1.20

4.40

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

462

3797

1.24

4.38

3.5

2.4

59.4

63.3

ml/min/173m2

1.33

194

1467

(21494814) CD8 cells/100 lymphocytes in Specimen

2.56

4.37

1.4

2.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

327

1.78

4.20

1.4

1.3

0.2

0.3

nmol/l

0.31

264

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

4.08

4.16

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

241

1844

1.32

4.10

1.8

1.7

ug/l

0.07

205

1587

(3021960) Folate [Moles/volume] in Serum or Plasma

1337

12080

1.14

4.09

1.6

1.5

20.2

20.3

nmol/l

0.06

1131

10209

(3016228) CD19 cells/100 cells in Blood

2.43

3.96

1.5

2.1

11.0

7.1

0.57

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

424

1.66

3.95

1.3

1.5

—

(44786800) Granulocytes/100 leukocytes in Body fluid

3.64

3.92

1.4

1.2

23.3

24.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

171

2.05

3.89

2.6

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

171

2.05

3.89

2.6

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

171

2.05

3.89

2.6

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

171

2.05

3.89

2.5

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

328

1.75

3.88

2.1

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

328

1.75

3.88

2.1

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

328

1.75

3.88

2.1

1.3

—

(3012501) Base excess in Blood by calculation

142

1011

1.41

3.82

3.9

4.2

2.6

2.5

mmol/l

0.11

685

(3011985) Renin [Units/volume] in Plasma

618

1.53

3.79

1.5

1.4

33.1

62.2

mu/l

2.19

549

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

3.34

3.75

1.8

1.4

74.2

84.4

ng/l

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

377

1.68

3.74

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

119

828

1.45

3.65

4.5

3.0

—

(3002032) Base excess in Venous blood by calculation

542

4614

1.19

3.62

4.2

3.6

1.8

1.9

mmol/l

0.31

449

3763

(3019150) Specific gravity of Urine by Refractometry

946

10596

0.87

3.62

4.1

4.2

1.0

kg/l

0.40

129

1582

(3010421) pH of Blood

162

1194

1.37

3.58

4.2

4.0

7.4

0.80

140

988

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

126

895

1.42

3.47

1.5

1.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

631

1.50

3.47

2.1

2.2

23.2

24.4

mg/l

0.08

162

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.98

3.41

5.4

5.2

63.6

40.0

ug/min

0.46

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.50

3.37

1.3

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

140

1020

1.38

3.35

1.2

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

366

3026

1.22

3.34

2.4

30.5

25.0

au/ml

0.30

130

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

178

1347

1.33

3.34

1.4

1.5

1.2

g/l

0.22

169

1268

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

182

1.93

3.32

1.1

2.7

2.6

ug/l

0.04

151

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

269

1.75

3.31

1.1

508.8

270.1

mg/l

0.71

237

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

284

1.73

3.31

1.1

1.2

90.3

37.6

mg/l

0.63

237

(3004716) Salmonella sp identified in Stool by Organism specific culture

242

1913

1.28

3.29

1.2

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

176

1.94

3.27

2.5

2.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

540

4640

1.18

3.26

4.2

3.6

5.9

5.8

kpa

0.57

526

4499

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

163

1.97

3.23

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

213

1.84

3.21

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

450

1.56

3.18

1.8

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

435

1.57

3.16

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

435

1.57

3.16

1.0

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

143

1058

1.36

3.13

1.4

1.3

—

(3008295) Osmolality of Serum or Plasma

452

1.56

3.12

1.3

1.4

282.9

277.8

mosm/kgh2o

1.38

341

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

132

965

1.38

3.12

1.3

7.9

24.7

e6/l

1.51

754

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

334

2758

1.22

3.11

1.3

50.5

49.6

au/ml

0.02

113

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

132

966

1.37

3.10

1.3

1.4

477.6

1199.4

e6/l

1.13

102

797

(3004588) Protein electrophoresis panel - Serum or Plasma

408

3437

1.20

3.10

2.5

1.5

—

(40768797) Stomach Pathology biopsy report

731

6459

1.15

3.08

1.3

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

105

741

1.42

3.05

1.3

1.4

—

(4027681)

210

1.81

3.03

1.3

1.2

—

(3003338) MCHC [Mass/volume]

3984

38604

1.10

2.90

24.4

17.7

331.7

332.2

g/l

3.25

3963

38275

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

273

1.69

2.89

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

141

1056

1.34

2.88

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

266

1.70

2.87

1.8

1.5

10.1

6.6

u/l

0.26

111

(3023419) Bacteria identified in Sputum by Culture

625

0.57

2.87

2.6

2.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

560

1.47

2.85

1.3

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

313

1.63

2.84

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

118

862

1.38

2.83

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.29

2.83

1.0

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

400

1.56

2.81

2.1

1.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.45

2.79

1.0

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

168

1298

1.30

2.78

1.4

287.4

286.1

ug/g

0.03

113

776

(3012565) Volume of 24 hour Urine

209

1.78

2.77

2.5

2.1

1846.8

1949.4

0.26

178

(3028026) IgM [Mass/volume] in Serum or Plasma

283

2328

1.23

2.77

1.9

1.4

1.2

g/l

0.65

250

2113

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.31

2.74

1.6

2.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

104

2.12

2.74

1.6

2.5

36894.3

33850.4

e6/l

0.03

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

542

1.46

2.70

1.2

1.3

—

nmol/l

—

(3026250) Tacrolimus [Mass/volume] in Blood

147

1.91

2.64

31.0

33.0

6.8

7.5

ug/l

1.17

136

(3037692) Legionella sp identified in Specimen by Organism specific culture

140

1.93

2.64

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

258

1.67

2.63

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

2420

23002

1.09

2.62

4.8

5.0

0.0

estimate

0.80

483

3957

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

579

1.44

2.62

1.3

315.1

275.8

pmol/l

0.45

436

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.55

2.61

1.6

1.5

16.7

7.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

229

1858

1.24

2.57

1.9

1.8

41.0

38.4

u/l

1.05

203

1584

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

3.60

2.57

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

2444

23266

1.09

2.52

3.7

0.0

estimate

1.60

466

3821

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

144

1109

1.31

2.48

1.3

1.2

538.7

524.1

mg/l

0.15

134

1038

(3020891) Body temperature

249

2048

1.23

2.47

4.8

—

(44806118)

454

1.48

2.47

1.4

—

(44790048)

454

1.48

2.47

1.4

—

(44790049)

454

1.48

2.47

1.4

—

(44790047)

454

1.48

2.47

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

590

1.41

2.39

1.3

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.12

2.36

1.0

1.1

—

(3042631) Mycobacterium sp identified in Specimen

594

1.40

2.31

2.2

3.1

—

(3014271) Vancomycin [Susceptibility]

301

1.57

2.26

2.8

2.9

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

414

1.48

2.26

3.6

2.9

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

208

1.69

2.26

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1040

11272

0.91

2.22

1.7

31415310.2

33091216.2

pmol/l

0.03

834

9208

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

5.56

2.21

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.56

2.21

1.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

146

1147

1.28

2.20

1.9

11.4

mg/l

0.04

138

1050

(3011397) Hemoglobin [Presence] in Urine by Test strip

1216

11289

1.10

2.19

3.4

3.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.34

2.18

2.1

—

(3044007) Cell count panel - Peritoneal fluid

2.02

2.15

2.1

2.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

347

1.50

2.11

1.3

11.4

12.0

mmol/l

0.20

(3024928) Oxygen saturation in Venous blood

131

1022

1.29

2.10

2.9

3.1

—

(3029075) Extractable nuclear Ab panel - Serum

116

1.90

2.10

1.0

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

614

1.37

2.10

1.2

1.3

0.6

2.3

nmol/l

0.50

589

(3048879) Bone marrow aspiration report

109

1.93

2.10

2.2

1.3

—

(3022475) Manganese [Moles/volume] in Blood

4.00

2.04

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

618

1.36

2.03

1.2

1.3

0.2

0.4

nmol/l

0.74

(3025941) Bacteria identified in Stool by Culture

282

2400

1.18

2.01

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

129

1011

1.28

2.01

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

129

1011

1.28

2.01

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.50

2.01

1.3

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.23

2.00

2.6

1.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

124

969

1.29

1.98

1.2

3.7

3.9

mmol/l

1.25

115

901

(3035350) Ketones [Presence] in Urine by Test strip

2400

22991

1.07

1.97

3.6

3.7

0.0

estimate

0.80

471

3894

(3003740) Influenza virus B Ag [Presence] in Specimen

477

1.41

1.97

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.28

1.97

5.2

4.6

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

112

1.88

1.95

1.5

4.9

2.2

0.51

(3033799) Differential panel - Peritoneal fluid

105

1.91

1.95

2.0

2.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

529

1.38

1.94

1.7

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1131

0.75

1.93

1.1

4.0

6.7

u/ml

—

103

(3002523) Influenza virus A Ag [Presence] in Specimen

479

1.40

1.93

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

694

6312

1.11

1.89

4.9

33.0

32.9

0.06

449

4225

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.96

1.89

1.2

1.1

—

(3016750) Collection duration of Urine

307

1.50

1.89

2.5

2.1

493.1

496.5

min

0.08

232

(3005988) Vibrio sp identified in Specimen by Organism specific culture

532

1.38

1.89

1.7

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

162

1316

1.24

1.89

1.5

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

863

7941

1.10

1.88

1.6

1.3

2.3

2.6

g/l

3.52

492

4555

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

136

1.77

1.86

1.5

1.4

56.5

63.9

0.46

111

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

205

1.61

1.85

1.1

1.0

1.1

u/l

0.13

(3023487) Leukocytes [#/volume] in Peritoneal fluid

122

1.81

1.83

1.8

2.8

24018.3

667.7

e6/l

0.46

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

726

1.31

1.82

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.12

1.81

11.4

12.4

4.1

5.4

mmol/l

2.57

(4010399)

314

3609

0.86

1.80

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

116

1.81

1.78

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

530

1.36

1.77

1.7

1.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

446

1.39

1.75

1.1

—

43.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

182

1510

1.21

1.75

3.5

1.5

1.3

2.3

ratio

—

133

(3033705) Calcium.ionized [Moles/volume] in Venous blood

664

0.69

1.75

2.7

2.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.93

1.74

3.6

2.1

—

(3041354) Potassium [Moles/volume] in Venous blood

675

0.69

1.74

2.6

2.1

4.1

mmol/l

0.12

669

(3035285) Chloride [Moles/volume] in Venous blood

675

0.69

1.74

2.6

2.1

105.7

106.0

mmol/l

0.26

669

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

464

1.38

1.73

1.1

—

2.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

558

1.35

1.73

1.2

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

721

6608

1.10

1.71

8.3

7.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

141

1143

1.24

1.70

3.5

3.2

0.8

nmol/l

0.34

109

898

(40767503) Oxygen content in Capillary blood by calculation

123

984

1.26

1.68

2.4

2.5

15.8

16.4

0.68

525

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.18

1.67

1.3

1.2

72.3

127.7

ug/l

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

276

1.49

1.65

1.5

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

285

1.48

1.63

1.2

1.0

3.2

8.6

nmol/l

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

565

1.33

1.62

5.1

6.3

12.2

12.0

mg/l

0.11

506

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

352

3108

1.14

1.61

1.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

540

1.34

1.60

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

182

1.60

1.59

1.1

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

433

3877

1.13

1.59

3.2

3.0

4.6

4.5

kpa

0.41

417

3745

(3048689) Calprotectin [Mass/mass] in Stool

551

5002

1.11

1.59

2.1

2.2

131.3

147.5

ug/g

0.37

435

3913

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

271

1.48

1.58

1.5

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.00

1.58

1.0

1.1

—

(4034850)

143

1734

0.82

1.57

10.6

9.9

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

249

1.49

1.52

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.59

1.51

1.1

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

233

1.51

1.2

1.1

23.0

24.6

u/l

0.08

169

(3007566) Smooth muscle Ab [Titer] in Serum

139

1143

1.22

1.51

1.3

1.2

566.0

158.8

titre

—

(3017569) Oxygen content in Arterial blood

270

0.55

1.50

1.5

1.9

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

234

1.50

1.48

1.2

1.1

80.0

84.7

u/l

0.20

176

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

226

1.51

1.48

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

184

1557

1.19

1.48

3.5

1.6

58.4

38.8

mg/l

0.42

156

1256

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

539

1.32

1.48

1.7

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

313

2762

1.14

1.47

2.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

235

1.49

1.46

1.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

184

1561

1.18

1.45

3.5

1.6

51.4

47.7

mg/l

0.25

154

1266

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

414

0.65

1.44

1.0

257.8

332.5

ng/l

0.70

269

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

236

1.49

1.43

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.73

1.43

2.8

3.4

—

(3014051) Protein [Presence] in Urine by Test strip

136

1126

1.21

1.40

2.0

2.2

—

(3025130) Human papilloma virus identified in Specimen

406

1.36

1.39

1.7

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

212

0.52

1.39

19.3

17.2

1694.5

1394.7

nmol/l

0.72

204

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.08

1.38

2.4

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

114

929

1.23

1.37

2.5

32.4

34.5

umol/l

0.41

789

(3019832) Treponema pallidum Ab [Presence] in Serum

243

2119

1.15

1.37

1.5

1.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

555

1.30

1.37

1.0

1.1

1.4

1.5

g/l

2.60

487

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.61

1.36

7.3

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

698

7526

0.92

1.36

1.3

13.6

14.4

u/ml

0.09

260

2840

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

420

0.67

1.36

1.0

30.9

45.3

ng/l

1.50

268

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

156

1314

1.19

1.35

1.4

1.6

0.2

g/l

0.42

146

1242

(4268621)

400

1.35

2.5

2.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

674

0.74

1.33

3.8

4.6

339.0

357.3

umol/l

0.37

571

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

417

0.67

1.32

1.0

537.4

717.4

ng/l

1.41

264

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

376

1.36

1.31

1.3

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

325

1.39

1.31

1.0

—

(3037121) Protein [Mass/volume] in Urine

176

1503

1.18

1.31

2.9

2.5

0.3

g/l

1.16

515

(1761482) Bacteria [#/volume] in Urine by Culture

113

1372

0.82

1.30

3.9

4.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.74

1.30

1.2

—

(3042733) HLA Ab [Presence] in Serum

121

1.66

1.30

5.5

5.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

377

1.36

1.30

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

377

1.36

1.30

1.3

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

137

1146

1.20

1.29

1.3

1.4

—

(3017732) Neutrophils [#/volume] in Blood

349

3131

1.12

1.29

3.0

2.9

4.1

e9/l

0.00

257

2265

(3007930) Methemoglobin/Hemoglobin.total in Blood

179

2082

0.86

1.28

3.5

4.8

0.9

0.39

166

1954

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

378

1.35

1.28

1.3

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

342

0.64

1.28

7.9

2.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.94

1.27

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

544

1.29

1.27

1.7

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.29

1.26

1.8

1.2

—

(3005033) Fetal Nuchal fold Thickness US

311

1.39

1.25

1.3

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

107

1.68

1.25

1.6

1.3

—

(3006245) CD3-CD19+ cells/100 cells in Blood

1.74

1.24

2.6

1.8

12.3

8.5

0.40

(3036525) Urea [Moles/time] in 24 hour Urine

2.40

1.24

4.5

2.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

118

0.42

1.24

1.4

1.6

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

203

0.54

1.24

12.9

12.3

1072.1

800.5

nmol/l

0.71

191

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

407

1.33

1.23

1.4

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

282

2507

1.13

1.22

2.6

0.2

0.3

e6/l

0.68

276

2445

(3047352) Trisomy 18 risk [Likelihood] in Fetus

313

1.38

1.22

1.3

1.4

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.63

1.21

1.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

557

1.28

1.21

1.7

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.16

1.21

2.0

2.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

2.16

1.21

1.8

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

322

1.37

1.21

1.3

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

183

2107

0.86

1.17

3.4

4.7

1.5

1.6

1.46

169

1976

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.93

1.17

1.1

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

561

1.27

1.16

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

182

1.49

1.15

1.1

70.1

548.3

ng/l

—

(4212803)

2.05

1.15

1.3

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

2.50

1.15

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.50

1.15

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

589

1.26

1.14

1.3

1.2

5.1

4.8

u/ml

0.05

252

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

199

1.46

1.14

1.5

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

199

1.46

1.14

1.5

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.85

1.13

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

586

0.75

1.12

1.3

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

748

7974

0.93

1.12

1.3

31.4

36.7

iu/ml

0.57

220

2452

(3025315) Body weight

2.00

1.12

6.0

5.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

656

1.24

1.09

1.2

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

131

1113

1.18

1.08

1.9

2.2

126.9

130.4

g/l

0.86

101

823

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

235

1.41

1.08

1.0

1.1

7.7

11.6

iu/ml

—

(3045414) Leukocytes [Presence] in Urine

243

2161

1.13

1.08

1.8

1.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

267

0.64

1.07

1.2

1.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

321

1.34

1.07

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

693

0.78

1.07

1.6

1.5

56.0

61.2

0.42

447

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

435

1.29

1.06

1.5

1.7

33.4

24.4

u/ml

0.44

103

(3028271) Lactate [Moles/volume] in Capillary blood

731

1.22

1.06

1.8

1.9

1.6

1.7

mmol/l

0.36

714

(3004616) Nuclear Ab [Presence] in Serum

602

0.76

1.05

1.5

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

322

1.34

1.05

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

322

1.34

1.05

1.1

—

(44806420)

179

0.56

1.04

2.0

2.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.79

1.04

1.3

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.79

1.04

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

283

3139

0.90

1.04

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

348

0.69

1.04

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

537

4987

1.08

1.03

2.3

2.4

7.5

ug/l

0.01

460

4316

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

221

1.40

1.02

1.2

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

221

1.40

1.02

1.2

1.4

—

(3008898) HLA-B27 [Presence]

107

1267

0.84

1.01

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

325

1.33

1.00

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

325

1.33

1.00

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

135

1160

1.17

0.99

1.3

1.2

448.3

1152.8

titre

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

326

1.32

0.98

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

293

2652

1.11

0.98

1.2

1.3

124.0

223.1

u/ml

4.64

273

2448

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.17

0.98

2.8

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

2.17

0.98

5.6

6.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

451

4871

0.92

0.97

1.7

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

327

1.32

0.97

1.2

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

191

1.42

0.94

1.2

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.61

0.93

2.6

1.8

30.7

27.1

0.34

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.22

0.93

10.5

1.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

562

1.23

0.92

1.2

1.3

—

(3004451) EKG impression Narrative

261

1.34

0.91

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

144

1255

1.15

0.90

2.4

3.1

24.3

24.8

mmol/l

0.68

125

1102

(3020191) Ethanol [Moles/volume] in Serum or Plasma

360

0.72

0.90

1.0

1.4

2.1

1.3

promille

1.37

277

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

141

1228

1.15

0.90

1.7

1.8

—

(3019977) pH of Arterial blood

278

0.68

0.89

1.6

2.3

7.4

—

104

(3008401) Mugwort IgE Ab [Units/volume] in Serum

473

0.76

0.88

1.0

1.1

0.5

0.7

u/ml

0.32

185

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

242

0.66

0.88

1.3

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.91

0.88

1.1

—

(3009343) pH of Capillary blood

333

3056

1.10

0.87

3.4

3.5

7.4

0.02

368

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.86

0.87

1.0

1.2

0.0

0.5

u/ml

—

(40768446) Kidney Pathology biopsy report

161

1.43

0.86

2.1

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

221

1.36

0.85

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

337

3101

1.09

0.84

3.4

3.5

5.0

5.2

kpa

3.64

311

2836

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

261

2373

1.10

0.84

2.8

2.6

0.7

0.40

254

2264

(3019309) Folate [Moles/volume] in Red Blood Cells

1086

10407

1.05

0.84

1.8

1138.3

1154.0

nmol/l

0.21

804

7807

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

633

1.20

0.83

1.6

1.8

902.5

3701.7

u/l

1.82

261

(42529582) MDA5 Ab [Presence] in Serum by Line blot

141

0.57

0.82

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

141

0.57

0.82

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

141

0.57

0.82

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

141

0.57

0.82

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.88

0.81

1.3

1.0

—

(3028433) Virus identified in Specimen by Culture

138

1.45

0.81

1.2

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

177

0.62

0.81

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

454

1.24

0.80

1.4

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

565

0.79

0.80

1.0

1.1

1.2

1.4

u/ml

0.12

218

(3020393) Adenovirus Ag [Presence] in Stool

1.82

0.79

1.2

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

486

0.78

0.79

1.1

3.0

u/ml

0.02

224

(1002224) Polysomnography panel

178

1592

1.12

0.78

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

320

2950

1.09

0.78

3.4

3.5

1.4

1.8

mmol/l

1.35

236

2143

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

402

1.25

0.78

1.3

1.5

—

(3002619) Bacteria identified in Specimen by Culture

1.59

0.78

1.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

123

1.46

0.77

2.3

2.0

1.0

ug/l

0.00

113

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

278

1.30

0.77

2.3

2.2

9.7

188.4

ug/min

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.08

0.74

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.67

0.74

2.0

2.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.64

0.73

2.0

2.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

172

1544

1.12

0.73

4.5

3.9

mmol/l

0.39

164

1449

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

193

1.35

0.73

1.1

1.2

—

(21494434) Karyotype in Bone marrow

361

1.25

0.72

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.52

0.72

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.92

0.70

1.2

—

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.92

0.70

1.0

—

(3011648) Oxygen content in Venous blood

372

1.24

0.70

1.8

2.2

10.4

11.1

0.43

372

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

111

973

1.14

0.69

1.5

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

308

0.75

0.69

1.2

1.3

92.6

168.9

pmol/l

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

266

1.28

0.68

2.1

1.5

7.1

6.5

u/l

0.12

227

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

114

1292

0.88

0.67

1.6

1.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

249

1.29

0.67

2.5

2.4

—

(44813793)

272

0.73

0.66

1.0

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

262

2418

1.09

0.66

2.8

2.6

1.2

0.01

262

2403

(3028300) Cannabinoids [Presence] in Urine

755

0.85

0.65

3.6

1.7

—

(3014891) Appearance of Pleural fluid

1.61

0.65

1.9

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

260

1.27

0.63

1.2

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

112

1.43

0.63

1.1

88.0

89.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

112

1.43

0.63

1.1

82.1

87.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

216

1.30

0.63

1.1

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

535

0.82

0.62

1.3

7.2

7.6

mmol/l

0.52

383

(1001926) Buprenorphine [Presence] in Urine by Screen method

589

0.83

0.62

4.2

1.6

—

(3027008) Opiates [Presence] in Urine

751

0.85

0.62

3.6

1.7

—

(3001186) Copper [Moles/volume] in Serum or Plasma

103

0.58

0.62

1.0

1.2

15.7

16.2

umol/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

302

0.76

0.62

1.6

1.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

208

1.30

0.61

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

187

0.69

0.60

1.5

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

748

0.85

0.60

3.6

1.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

400

0.80

0.59

1.3

1.2

—

44.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

499

4737

1.06

0.59

2.4

3.0

233.3

223.3

ng/l

0.18

448

4343

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.44

0.59

2.0

2.9

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.44

0.59

1.3

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

363

1.21

0.58

1.2

1.4

20.0

80.0

titre

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.71

0.57

1.5

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.48

0.57

1.4

1.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.48

0.57

1.0

—

(3021901) Oxygen saturation in Capillary blood

100

886

1.13

0.57

2.2

2.7

—

(3044009) aPTT.lupus sensitive (LA screen)

1.67

0.56

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

605

1.16

0.56

1.3

1.2

2.9

4.1

u/ml

0.29

190

(3000034) Microalbumin [Mass/volume] in Urine

517

0.83

0.56

3.0

3.1

19.0

35.5

mg/l

1.34

380

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

176

1.31

0.56

3.0

2.4

—

(3016879) Cocaine [Presence] in Urine

689

0.85

0.56

3.8

1.8

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.46

0.56

1.4

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

107

1.40

0.55

1.7

—

(3017704) Immunofixation for Urine

266

1.24

0.55

1.4

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

339

0.80

0.53

1.0

1.1

0.9

2.8

u/ml

—

130

(3006462) Nitrate [Presence] in Urine

222

1.26

0.53

3.9

3.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

258

1.24

0.53

1.3

1.2

—

(3003181) Sodium [Moles/volume] in Urine

853

1.13

0.53

1.3

61.9

63.5

mmol/l

0.15

683

(3019174) dRVVT (LA screen)

1.54

0.53

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.54

0.53

1.0

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.45

0.53

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

117

1053

1.11

0.53

1.4

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

165

1797

0.92

0.52

1.2

0.3

0.8

u/ml

2.29

176

(3027944) Amphetamines [Presence] in Urine

736

0.87

0.51

3.0

1.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

170

1.30

0.51

6.3

1.6

144.2

151.9

0.19

159

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

425

1.18

0.51

1.9

1.8

13168.0

1740.0

titre

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

109

1.38

0.50

1.1

—

(3015183) Erythrocyte sedimentation rate

168

0.71

0.50

1.2

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.46

0.50

1.2

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1092

0.90

0.49

3.0

3.7

26.9

27.6

mg/l

0.07

718

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.56

0.48

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

367

0.82

0.48

1.0

1.1

0.5

2.4

u/ml

—

140

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

178

0.73

0.48

1.0

1.1

1766.8

1636.5

miu/ml

0.16

178

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

234

0.77

0.48

1.3

5.9

6.1

mmol/l

0.36

222

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

698

0.87

0.47

1.0

1.1

32.7

1405.3

iu/ml

0.90

149

(3000492) Spirometry study

430

4099

1.05

0.47

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

701

1.13

0.47

1.7

1.6

0.6

0.8

g/l

2.49

532

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

236

1.23

0.46

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

299

0.80

0.46

1.0

1.1

0.0

0.3

u/ml

—

(3001019) Free T4 and TSH panel - Serum or Plasma

182

1688

1.08

0.46

1.5

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

114

1035

1.10

0.46

2.3

2.8

7.9

kpa

0.02

102

954

(1761868) Lipid panel - Serum or Plasma

1538

15046

1.03

0.46

3.0

3.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.62

0.45

1.0

1.7

—

88.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

749

0.88

0.45

1.4

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

119

0.67

0.45

6.8

6.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.43

0.45

1.1

1.2

1.1

1.4

mmol/l

—

(3000285) Sodium [Moles/volume] in Blood

0.59

0.45

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.40

0.45

1.1

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

192

2061

0.93

0.45

1.0

1.1

—

(21494755) Public health laboratory ask at order entry panel

277

2936

0.94

0.45

1.3

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

220

2060

1.07

0.44

1.5

—

(3004775) Volume in Urine collected for unspecified duration

452

1.15

0.42

2.6

2.3

670.3

620.9

0.40

307

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.43

0.42

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

387

1.16

0.42

1.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.56

0.42

2.2

1.8

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.56

0.42

1.6

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.52

0.41

1.2

1.6

0.6

0.7

umol/l

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.9

—

12.4

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.41

0.0

4.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

351

1.17

0.41

1.2

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

105

1.33

0.41

1.8

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.36

0.41

1.1

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

719

1.11

0.40

1.3

1.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

358

0.84

0.40

1.0

1.1

—

(3034426) Prothrombin time (PT)

141

1.28

0.40

1.1

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

144

1335

1.08

0.39

1.6

1.5

10019.9

13440.5

e6/l

0.89

971

(3024891) Influenza virus A+B Ag [Presence] in Specimen

116

1066

1.09

0.39

1.1

1.2

—

(3047181) Lactate [Moles/volume] in Blood

138

1488

0.93

0.38

3.9

5.9

1.3

mmol/l

0.20

121

1310

(3041096) Erythrocytes [Presence] in Urine by Automated

1213

11863

1.03

0.38

3.5

3.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

705

0.89

0.37

1.4

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1323

12959

1.03

0.37

1.6

1.3

mmol/l

0.90

1087

10748

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

113

0.71

0.37

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.35

0.37

1.0

1.1

0.0

3.0

u/ml

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

107

1.31

0.37

1.6

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1666

16953

0.98

0.37

4.2

4.0

6.7

8.8

mg/mmol

1.47

1028

10752

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

801

1.10

0.36

1.2

98.9

27.6

u/l

1.19

686

(3019060) Gas panel - Arterial blood

346

3310

1.05

0.36

3.9

4.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

227

2150

1.06

0.35

1.6

1.5

11.6

17.6

u/ml

—

(3028717) Thiamine [Mass/volume] in Blood

1.40

0.35

1.2

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1750

17782

0.98

0.34

3.9

4.0

—

(3035933) Granulocytes/100 leukocytes in Blood

1.34

0.34

1.3

1.9

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.33

0.33

1.0

1.2

2.1

1.8

umol/24h

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

476

0.88

0.32

1.2

1.1

—

1.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

203

1924

1.06

0.32

4.0

3.8

24.6

24.9

mmol/l

0.74

182

1748

(3018572) Chloride [Moles/volume] in Blood

1039

0.92

0.31

4.5

6.7

105.5

104.9

mmol/l

0.79

930

(3039000) Anion gap in Blood

1038

0.92

0.31

4.5

6.7

11.1

11.4

mmol/l

0.34

929

(3014148) Varicella zoster virus Ab [Titer] in Serum

400

0.87

0.30

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

100

0.70

0.30

1.9

1.5

132.9

118.1

ng/l

—

100

(3027923) C peptide [Moles/volume] in Serum or Plasma

272

0.84

0.30

1.4

1.2

1.3

nmol/l

0.17

209

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.30

0.30

2.4

2.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

212

1.18

0.30

1.1

1.2

73.0

48.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.27

0.30

1.4

1.8

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

163

0.80

0.29

1.0

1.1

101.2

93.5

0.49

126

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

356

0.87

0.29

1.4

1.2

104.0

171.4

titre

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

104

968

1.08

0.29

1.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

122

1143

1.07

0.28

3.9

1.5

—

(3044941) Cell count panel - Synovial fluid

843

1.08

0.28

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

270

0.85

0.28

1.0

1.1

—

(3024932) HLA-DR beta [Type]

103

1.26

0.28

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

128

1361

0.94

0.27

1.5

1.6

0.1

2.5

iu/ml

0.64

299

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

460

1.11

0.27

3.7

3.8

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

261

1.15

0.27

1.3

1.4

—

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

269

0.85

0.27

1.1

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

118

0.76

0.27

4.3

7.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

150

0.80

0.27

1.3

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

150

0.80

0.27

1.3

2.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

113

1.24

0.26

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

416

0.89

0.26

1.0

1.1

0.0

1.7

u/ml

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

268

0.86

0.26

1.1

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

104

1.25

0.26

1.3

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.28

0.26

1.4

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

124

1.21

0.24

1.1

—

(3024471) HLA-A [Type]

106

1.23

0.23

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.28

0.23

1.0

2.9

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

463

0.91

0.22

1.4

7.3

6.7

g/l

0.24

327

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

232

0.86

0.22

1.1

—

(4211845)

247

1.13

0.22

3.9

2.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

125

1.20

0.22

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

462

0.91

0.22

1.4

2.3

2.9

g/l

1.80

326

(3024139) IgG subclass 3 [Mass/volume] in Serum

462

0.91

0.22

1.4

0.7

0.4

g/l

0.40

328

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.22

0.22

1.0

1.1

14.6

16.3

u/l

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

343

1.11

0.22

1.4

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

231

0.87

0.21

1.3

1.1

ratio

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

468

1.09

0.21

1.2

1.1

—

(3000012) Reticulocyte production index

267

1.12

0.21

1.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.21

0.0

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

154

1.17

0.21

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

1.16

0.21

1.0

—

(4306422)

585

1.08

0.21

1.3

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

576

1.08

0.20

2.8

19.9

6.6

7.4

mmol/l

1.55

472

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.20

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.4

—

2.3

—

(3029937) Albumin [Presence] in Urine by Test strip

1278

12616

1.02

0.20

4.2

4.1

0.0

estimate

1.74

452

3846

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1005

0.94

0.20

1.2

—

16.9

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.22

0.20

1.3

1.1

—

(3020650) Glucose [Presence] in Urine

111

0.81

0.20

1.1

1.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

110

1158

0.95

0.20

1.4

1.8

44.9

43.9

nmol/l

0.19

110

1104

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

510

0.92

0.19

1.1

1.5

3.2

u/ml

1.53

208

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

111

1167

0.95

0.19

1.2

2.0

8.1

u/ml

—

124

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

154

0.84

0.19

1.1

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

140

1462

0.96

0.19

1.9

1.8

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.13

0.18

1.5

1.0

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

164

0.85

0.18

2.6

1.9

46.8

51.9

ug/l

0.21

159

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

223

1.12

0.18

1.7

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

185

1.14

0.18

1.4

2.3

107.2

146.3

umol/l

0.53

102

(3000330) Specific gravity of Urine by Test strip

256

2637

0.97

0.18

3.1

3.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

216

0.88

0.17

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

329

1.09

0.17

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

142

0.84

0.17

1.2

1.3

43.4

35.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.13

0.17

1.3

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

110

1.18

0.17

1.2

1.4

—

(4133840)

110

1.18

0.17

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

465

1.08

0.17

1.1

1.3

1.4

nmol/l

0.05

416

(3020491) Glucose [Moles/volume] in Blood

359

1.09

0.16

2.2

7.6

6.7

mmol/l

0.73

238

(3034274) Bile acid [Moles/volume] in Serum --fasting

282

1.10

0.16

1.4

1.7

8.4

6.6

umol/l

0.29

194

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

139

1.15

0.16

1.4

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

930

9419

0.98

0.15

1.3

1.2

1.7

1.9

u/ml

0.30

213

2482

(3022313) Gas panel - Capillary blood

229

2228

1.03

0.15

3.8

3.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

274

2673

1.03

0.15

1.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.81

0.14

1.0

1.1

—

3.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

275

1.09

0.14

1.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

131

1.15

0.14

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

122

1.15

0.13

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

143

1385

1.03

0.13

2.5

2.3

69.2

120.5

ug/min

1.56

810

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

114

1181

0.96

0.12

1.2

2.9

5.0

u/ml

—

196

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

148

0.88

0.12

1.3

1.1

—

(3044927) Protein electrophoresis panel - Urine

570

0.95

0.12

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

104

1.15

0.12

1.2

1.1

—

(4094501)

144

1397

1.03

0.12

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

603

6110

0.99

0.12

1.3

509.3

525.5

titre

0.08

116

1344

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

824

0.96

0.12

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

313

0.93

0.12

1.4

1.2

0.1

1.1

u/ml

1.52

151

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

844

0.96

0.12

1.6

1.9

198.2

198.8

pmol/l

0.02

790

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

137

0.88

0.12

4.2

7.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

230

2249

1.02

0.11

1.6

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

146

1502

0.97

0.11

1.3

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

172

1676

1.03

0.11

1.5

1.6

116.7

318.6

titre

—

(3045424) Erythrocytes [Presence] in Urine

792

0.96

0.11

1.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

446

1.05

0.10

1.3

1.4

—

24.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

146

0.89

0.10

1.9

1.5

7.3

9.1

ug/l

1.85

146

(3009508) Creatinine [Moles/volume] in Urine

1637

16470

0.99

0.10

3.4

3.2

7.3

7.4

mmol/l

0.98

1373

13734

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

889

1.04

0.10

1.2

58.7

41.1

u/ml

—

102

(36660697) Celiac disease serology panel - Serum

348

3426

1.02

0.10

1.2

—

(3021788) Differential panel - Synovial fluid

101

979

1.03

0.09

1.5

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

412

0.95

0.09

1.7

2.2

2.3

1.8

u/field

0.19

157

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.09

0.09

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

645

0.96

0.09

1.3

—

(4062490)

462

0.95

0.09

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.11

0.09

1.2

1.5

43.8

43.3

umol/l

—

(3018133) Calcium [Moles/volume] in Urine

1.05

0.08

2.0

1.7

2.5

2.8

mmol/l

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.05

0.08

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

175

1.09

0.08

1.3

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.83

0.08

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

491

0.96

0.08

6.6

2.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.06

0.08

1.1

1.9

13.7

18.1

umol/l

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.03

0.07

1.3

7.4

458629.0

nmol/l

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

314

3181

0.99

0.07

6.4

6.9

24.7

24.6

mmol/l

0.23

292

2940

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

146

1431

1.02

0.07

1.8

1.7

2.6

3.7

mg/l

1.15

109

1012

(3022621) pH of Urine by Test strip

320

3240

0.99

0.07

2.8

3.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.83

0.07

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.07

0.07

1.4

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

118

1.10

0.07

1.1

1.3

—

(3012516) Albumin [Mass/volume] in Urine

1600

16069

0.99

0.07

3.5

3.2

564.6

307.2

mg/l

1.08

1004

10238

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

105

0.86

0.06

1.1

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

325

1.05

0.06

1.3

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

111

0.90

0.06

1.5

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

446

0.96

0.06

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

237

1.06

0.05

1.1

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

320

3170

1.01

0.05

3.0

3.2

126.8

130.2

g/l

1.75

311

3081

(3039443) Prostate specific Ag panel - Serum or Plasma

862

1.02

0.05

1.8

1.6

—

(3022689) Creatine [Moles/volume] in Urine

171

0.94

0.05

1.3

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

120

1.08

0.04

1.2

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

594

0.98

0.04

1.2

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

964

1.02

0.04

1.8

1.6

0.9

0.8

nmol/l

0.21

794

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

734

0.98

0.03

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

196

1941

1.01

0.03

1.1

35.0

194.0

titre

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

131

1.07

0.03

1.0

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

329

1.03

0.03

1.5

1.4

1.0

0.9

g/l

0.33

329

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

462

4644

0.99

0.03

1.5

1.7

1.5

0.09

398

3995

(40761535) Cells panel - Urine sediment

433

4307

1.01

0.03

3.5

3.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

161

1.06

0.03

1.0

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

221

1.04

0.03

1.3

1.2

133.7

138.1

nmol/l

0.23

221

(4015189)

158

0.95

0.02

1.8

2.6

—

(4146454)

610

1.02

0.02

2.7

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

192

1.04

0.02

3.1

1.8

16.7

197.8

ug/l

0.68

181

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

163

1618

1.01

0.02

1.7

1.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

509

0.98

0.02

1.6

1.5

34.1

28.9

0.42

331

(3010144) Erythrocytes [#/volume] in Synovial fluid

531

1.02

0.02

1.3

194654.4

191110.6

e6/l

0.01

364

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

113

1.06

0.01

1.1

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

283

1.02

0.01

9.2

10.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

124

1.05

0.00

1.5

1.6

8.1

8.6

mmol/l

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

256

0.98

0.00

1.8

1.9

1.8

u/field

0.03

173

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

253

2524

1.00

0.00

1.7

1.8

—

(40757373) Influenza virus identified in Isolate

1.02

0.00

2.0

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

132

0.98

0.00

1.2

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

222

0.99

0.00

1.0

1.1

—

3.8

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

115

1.04

0.00

1.0

1.1

—

(4024509)

488

1.00

0.00

1.3

1.6

—

(3024263) Appearance of Synovial fluid

285

1.02

0.00

2.2

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

305

1.02

0.00

2.6

2.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.04

0.00

1.2

0.9

0.7

umol/24h

—

(3009871) Measles virus Ab [Titer] in Serum

126

1.03

0.00

1.6

1.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

136

1.03

0.00

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

186

1.02

0.00

1.3

1.2

40.2

39.9

g/l

0.03

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

237

1.01

0.00

3.1

4.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

237

1.01

0.00

5.5

5.1

788.0

53.6

u/ml

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

584

0.99

0.00

1.1

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

101

0.99

0.00

1.1

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

592

5924

1.00

0.00

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

251

1.00

0.00

2.2

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

821

1.00

0.00

1.2

258.0

217.9

miu/ml

0.39

360

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

2.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.98

0.00

1.3

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

2.3

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

0.00

0.0

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.94

0.00

8.6

11.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.94

0.00

1.0

1.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

152.3

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.94

0.00

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.99

0.00

1.0

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

2.3

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.91

0.00

3.3

2.8

0.3

0.5

u/field

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

43.7

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.91

0.00

1.1

1.5

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

1.4

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

3.9

—

18.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.02

0.00

1.0

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.97

0.00

1.0

1.1

85.0

59.7

u/ml

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_MELANOMA_SKIN_EXALLC – Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

GWS hits: 25

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant melanoma of skin, excluding all cancers (controls excluding all cancers) (C3_MELANOMA_SKIN_EXALLC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints